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Abstract
Alcohol abuse induces many disorders including depression, metabolic syndrome, and
sleep disturbances. The strong link between alcohol abuse and sleep problems, along
with the close connection between sleep and circadian rhythms, led us to investigate
ethanol’s effects on the circadian clock. Previous work has shown that acute ethanol
blocks photic phase shifts in vivo and glutamatergic phase shifts in vitro. However, neural
systems become tolerant to ethanol across different timeframes. Despite both ethanol
tolerance and ethanol withdrawal syndrome being listed as criteria for developing alcohol
use disorders, little is known about how ethanol tolerance and withdrawal induced
hyperexcitability develop and how they differ. Because previous work has shown that
acute tolerance to ethanol occurs in the SCN, we tested whether additional forms of
tolerance as well as withdrawal induced sensitization develop in the SCN and we
identified distinct changes across all of these conditions with respect to N-methyl-daspartate (NMDA) receptor related proteins. Our hypotheses were that rapid tolerance,
chronic tolerance, and withdrawal induced sensitization occur in the SCN, that these
conditions are associated with increased expression of NR2B containing NMDA
receptors, and that the extent to which these changes occur differ across tolerance and
withdrawal paradigms. We found that rapid tolerance develops in vivo and in vitro with
respect to a loss in phase shift inhibition. Additionally, we have discovered chronic
tolerance and withdrawal induced sensitization to glutamate also occur in vitro.
Furthermore, we compared phosphorylation and total expression of NMDA receptor
subunits and NMDA receptor-regulating proteins across the drinking models that induce
rapid tolerance, chronic tolerance, or withdrawal. We found no changes during rapid
tolerance to ethanol. In contrast, we saw an increase in the ratio of total expression of
v

NR2B/NR2A during both chronic tolerance and withdrawal from EtOH, an increase in Tyr
1472 phosphorylation during withdrawal, and an increase in mature BDNF and TrkB
phosphorylation during withdrawal. Altogether we demonstrated the power of utilizing the
SCN for investigating ethanol induced plasticity by identifying rapid tolerance, chronic
tolerance, and withdrawal induced sensitization. Additionally we found that the cellular
effects of ethanol during these forms of tolerance and withdrawal differ.
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Chapter 1
General Introduction
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Background
Alcohol causes a wide range of changes in the physiology, cell signaling, and
genetic regulation of many brain regions. Prolonged use of alcohol can lead to alcohol
use disorder (AUD). The diagnostic statistical manual of mental disorders volume 5
(DSM-V) suggests that the two primary components of AUD are drug seeking and drug
dependence (APA, 2013). Focusing on the latter, the criteria describing dependence
includes seeking alcohol even when aversive to health, cravings, developing tolerance,
and experiencing symptoms of withdrawal after sudden abstinence (Hagman and Cohn
2011; APA, 2013). The neurocircuitry mediating the effects of alcohol relevant to the
development of addictive behavior include the prefrontal cortex, amygdala, nucleus
accumbens, hypothalamus, thalamus, and ventral tegmental area (Noori et al 2012).
However, ethanol (EtOH) modifies signals in many other regions of the brain that have
been used to investigate EtOH related phenomena. In this research we focused on the
suprachiasmatic nucleus (SCN) in the lower hypothalamus, as a model system for
studying EtOH tolerance and withdrawal.
The SCN houses the endogenously driven primary oscillator that regulates the
timing of circadian rhythms over 24 hours. The firing rate of neurons in the SCN exhibits
a circadian rhythm that increases and peaks during the day and decreases at night. This
oscillation in neuronal firing is one of the primary output signals from the SCN that
coordinates the timing of behavior and physiology throughout the body (Colwell 2011).
The rhythm of neuronal action potentials in the SCN is controlled by a feedback
mechanism involving key clock genes known as the transcription/translation feedback
loop (TTFL; Hastings et al 2008). The TTFL allows for synchronizing or entraining the
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timing of endogenous rhythms to external environmental cues like light. In a properly
functioning clock the internal rhythms, including the SCN neuronal activity rhythm,
maintain synchrony with the external environment in a process known as entrainment.
Entrainment ensures the correct timing of physiological processes like sleep, blood
pressure, and feeding patterns (Saper et al 2005; Dominguez-Rodriguez et al 2010;
Schibler et al 2003). Acute disruptions in clock function can occur when changing time
zones or when working shift schedules. Continuous circadian disruptions over long
periods can lead to problems such as metabolic syndrome and certain forms of cancer,
and are even linked to Alzheimer’s disease (Maury et al 2010; Takahashi et al 2008; van
Someran et al 1996).
Anatomically the SCN is divided into two regions, the ventral core and dorsal shell.
The ventral core receives glutamatergic inputs from the optic tract. The ventral core also
receives neuropeptide Y and gamma aminobutyric acid (GABA) inputs from the
intergeniculate leaflet and serotonergic and GABAergic inputs from the dorsal raphe
nucleus (Moore and Silver 2008). The core then communicates these signals to the shell,
however the circuitry involved in ventral to dorsal communication is still under
investigation. After receiving inputs from the core, the dorsal shell sends circadian outputs
mainly to the hypothalamus which then relays these signals to other brain regions
(Abrahamson and Moore 2001).
We and others have demonstrated that EtOH consumption can disrupt the SCN
clock, including altering its endogenous period and inhibiting normal phase regulation
(Brager et al 2010; Brager et al 2011; Ruby et al 2009; Rosenwasser et al 2005; McCulley
et al 2013; Prosser et al 2003; McElroy et al 2009; Prosser and Glass 2009; Lindsay et al
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2014). At least some of these effects are due to actions specifically within the SCN, since
EtOH applied to the SCN via microdialysis or applied in vitro inhibits phase resetting
(Prosser 2003; Prosser et al 2008; Prosser and Glass 2009; Brager et al 2010; Ruby et
al 2009). Conversely, other effects appear to involve actions outside the SCN (Pickard et
al 1996; Graff et al 2006; Prosser et al 2008). The combined effects of EtOH on the
circadian system impair proper adjustments to changes in environmental cycles, and
could contribute to the circadian disruptions seen in alcoholics (Rouhani et al 1990;
Rajakrishnan et al 1999; Kubota et al 2002; Rosenwasser et al 2005). This is supported
by multiple reports showing disruptions in physiological rhythms in alcoholic patients
(Adinoff et al 1991; Röjdmark et al 1993; Kühlwein et al 2003). Given that poor sleep
quality is a common cause of relapse drinking (Gillin et al 1994; Brower, 2001; Brower
2003) and disrupted circadian rhythms can contribute to impaired sleep (Dijk et al 2000;
Crowley 2011; Ditisheim et al 2013), a better understanding of how EtOH affects the
circadian clock is important.
As mentioned above, the development of alcohol tolerance is one symptom of
alcohol dependence. Many labs have investigated the mechanisms of tolerance in hopes
of discovering effective treatments for, or ways to prevent, alcohol dependence. The most
heavily studied forms of tolerance, known as acute, rapid, and chronic tolerance, differ
with respect to how quickly they develop after initial alcohol consumption. In experiments
using mammalian models, acute, rapid, and chronic tolerances develop within minutes,
to hours, to days of alcohol consumption, respectively. The timing of these forms of
tolerance is consistent with that seen in humans (Bierness and Vogel-Spott 1984;
Hiltunen and Jarbe 1990; Bennett et al 1993). Experimentally, the different timing of
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development for these forms of tolerance makes them easily distinguishable. Although
the cellular mechanisms associated with these tolerance types are thought to differ
(Khanna et al 1991a; Grobin et al., 1998; Roberto et al., 2006), there is little direct
evidence of this based on within-experiment comparisons. Identifying differences in the
mechanisms of tolerance could clarify the processes through which dependence to
alcohol develops.
Alcohol withdrawal-induced hyperexcitability is another characteristic of alcohol
dependence. Research has shown that sudden abstinence after long-term EtOH use
leads to a variety of changes in neuronal signaling that are distinct from those seen during
tolerance. For instance, withdrawal from EtOH increases presynaptic glutamate release
in many brain regions (Christian et al., 2013, Faingold et al., 2000, Kash et al.,
2009 and Roberto et al., 2004). Other studies have shown changes in pharmacological
properties of GABA receptors following EtOH withdrawal (Veatch and Becker 2005;
Kumar et al 2009; Linsenbardt & Boehm 2010). Although EtOH-induced changes in
glutamate and GABA have been studied extensively using a wide variety of experimental
paradigms, it is noteworthy that few studies have compared the changes in neuronal
signaling associated with chronic EtOH exposure and EtOH withdrawal in a single
experiment.
Similar to other brain regions, we have shown that acute tolerance to EtOH
inhibition of glutamate-induced phase resetting develops in the SCN in vitro (Prosser and
Glass 2009). Conversely, evidence suggests that chronic tolerance to EtOH does not
develop with respect to inhibition of in vivo photic phase resetting (Brager et al 2010).
However, results from another study suggest that the lack of chronic tolerance seen in
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those experiments may have been due to using forced EtOH consumption versus freechoice EtOH drinking (Seggio et al 2009). With respect to the effects of EtOH withdrawal
on circadian rhythms, enhanced photic phase shifts are seen during withdrawal in
hamsters (Ruby et al, 2009), while EtOH withdrawal does not alter photic phase shifts in
mice (Brager et al, 2010). On the other hand mice exhibit altered free-running circadian
periodicity after withdrawal from 12 days of EtOH exposure (Logan et al 2012). In light of
these variable results, we have investigated whether multiple forms of EtOH tolerance
and withdrawal-induced glutamate sensitization occur in the SCN, using in vitro
glutamate-induced circadian rhythm phase shifts as our primary experimental output.
Moreover, we used multiple drinking paradigms to directly compare the different forms of
EtOH-induced plasticity. At a functional level, we assessed changes in ionotropic
glutamate (N-methyl-D-aspartate; NMDA) and GABA(A) receptor expression and
phosphorylation in response to different EtOH consumption paradigms.
Our approach is unique in that we are comparing the cellular changes that occur
during rapid and chronic tolerance and during withdrawal-induced glutamate sensitization
in a single model system. Our goals are two-fold: to clarify the cellular mechanisms
through which EtOH affects the SCN circadian clock, and to better understand the cellular
changes that occur during and after EtOH consumption. Given the epidemiological
evidence linking alcohol tolerance and withdrawal symptoms to the development of
alcohol abuse and relapse, the data from these experiments could be used to develop
novel cellular targets for pharmacological intervention of AUD.
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Circadian rhythms and the suprachiasmatic nucleus
The transcriptional/translational feedback loop
The circadian clock in the mammalian suprachiasmatic nucleus (SCN)
synchronizes daily endogenous rhythms to external environmental cues. The mammalian
circadian oscillator includes a transcriptional/translational feedback loop (TTFL) that
functions over the 24 hour circadian day while maintaining synchrony with external timing
cues (Figure 1.1a and b). At sunrise, the transcription factors CLOCK and Bmal1 dimerize
and activate transcription of two families of genes, Period (Per) and Cryptochrome (Cry;
Reppert and Weaver 2002). Per and Cry encode proteins that accumulate slowly over the
course of the day (Figure 1.1a). As PER and CRY proteins accumulate, become
phosphorylated, and dimerize, they enter the nucleus and negatively feedback onto
CLOCK and Bmal1 to suppress transcription, with protein levels (and transcriptional
inhibition) peaking near the middle of the night (Figure 1.1b). Over the remainder of the
night, protein and mRNA levels decrease, allowing for another cycle of transcription to
begin the next day (Reppert and Weaver 2002). Other genes such as Rev-erbα and
RORα/β also coordinate the transcription of clock genes, particularly Bmal1. This cycling
of transcriptional activation and inhibition maintains the timing of behaviors and
physiological processes over 24 hours (h), and provides the mechanism through which
the clock can respond to external timing cues.
Photic phase shifts
The phase of the circadian clock adjusts to changes in environmental cues, such
as seasonal shifts in day length, or remaining active at irregular times, as well as daylight
savings, travelling across time zones, and shift work (Stevens 2009; Kantermann et al
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2007). The process through which circadian clocks adjust to timing stimuli is known as
phase resetting. In mammals, photic phase shifts occur when light shines on the eyes at
night and activates retinal ganglion cells. The signal propagates via the optic nerve to the
SCN, causing glutamate to be released from retinal ganglion cells onto SCN neurons.
The glutamate then binds to and activates NMDA receptors (Ding et al 1997; Mintz et al
1999; Wang et al 2008), a critical step in the photic phase shifting process (Ebling 1996).
Concurrent activation of the receptor tropomyosin receptor kinase B (TrkB) by brainderived neurotrophic factor (BDNF) is also necessary for phase shifts (Liang et al 1998;
Liang et al 2000; Allen et al 2005; Kim et al 2006; Michel et al 2006; Mou et al 2009). This
leads to TrkB autophosphorylation, which can activate kinases that phosphorylate NR2B
subunits of NMDA receptors. The importance of activating NR2B-containing NMDA
receptors for photic phase shifts was shown in experiments that blocked glutamateinduced phase shifts with ifenprodil, an NR2B selective antagonist (Bendova et al 2012).
Upon activation of NMDA and TrkB receptors, calcium ions (Ca2+) enter the cell, activating
a variety of downstream signaling pathways. Eventually this leads to phosphorylation of
the transcription factor cAMP response element binding protein (CREB), resulting in an
increase in transcription of multiple genes, including the clock genes, Per1 and 2
(Kornhauser et al 2002; Yokota et al 2001). Increased Per gene transcription will either
phase delay or phase advance the clock (or have no effect) depending on the time of Per
gene transcription (Shigeyoshi et al 1997; Yan et al 1999; Yan and Silver 2002).
Therefore, the timing of the light-induced glutamate release in the SCN is paramount for
determining whether it will induce a phase delay, a phase advance, or no shift. In vitro
experiments investigating the cellular processes associated with photic phase shifts
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typically bypass activation of retinal ganglion cells and directly apply glutamate onto SCN
tissue (Ding et al 1997; Tischkau et al 2000; Prosser and Glass 2009; Lindsay et al 2014).

Ethanol, ethanol tolerance, and their effects on glutamate and GABA signals
Ethanol consumption paradigms
EtOH research is challenging in part because EtOH has many targets. Acutely,
EtOH affects extracellular proteins, receptor proteins, second messengers, transcription
factors, and genetic regulators. However, it is well known that acute EtOH primarily
inhibits glutamate signaling (Lovinger et al 1989) and enhances GABA signaling (Allan
and Harris, 1986; Suzdak et al., 1986; Ticku et al., 1986). This is largely due to acute
EtOH’s ability to modify glutamate receptor and GABA receptor function, decreasing
cation flow through NMDA channels and increasing Cl- ion influx through GABA(A)
channels (Roberto et al 2004; Proctor et al 2006; Moykkynen and Korpi 2012; Hughes et
al 2013; Allan and Harris, 1986; Suzdak et al., 1986; Ticku et al., 1986; Wei et al 2004;
Olsen et al 2007). This change in receptor activity by acute EtOH involves modulation of
multiple

receptor

components

including

subunit

expression,

post-translational

modification, and localization of receptors. Together, these acute effects of EtOH result
in decreased neuronal activity, since glutamate generally increases neuronal activity and
GABA inhibits neuronal activity (Crews et al 1996; Diamond and Gordon 1997).
A second complication is that the effects of EtOH can change over time due to the
development of tolerance at cellular and physiological levels. While acute EtOH inhibits
glutamate signaling, chronic ethanol leads to compensatory increases in glutamate
release and/or receptor activation (Hendricson et al 2004; Roberto et al 2004; Clapp et al
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2010; Wu et al 2010). Likewise, while acute EtOH enhances GABA(A) receptor signaling,
chronic EtOH can decrease GABA signaling (Mihic and Harris, 1997; Kumar et al 2003;
Liang et al 2007; Abramian et al 2010; Ron and Messing 2013). Compensatory changes
in the brain in response to sustained EtOH exposure occur over varying time periods,
leading to a variety of changes in receptor subunit composition, phosphorylation, and
localization (Chandler et al 1998). These changes are believed to underlie the
development of alcohol dependence and alcohol abuse. However, forcing animals to
consume EtOH can generate distinct EtOH effects, as shown in multiple studies (Khanna
1991a; 1993; Grover et al 1994; Ravindran et al 2007; Liang et al 2007; Pietrzykowsky
and Triestman 2008; Prosser and Glass 2009; Seggio et al 2009; Gonzalez et al 2012;
Lindemeyer et al 2014). Therefore, voluntary EtOH consumption may be preferable to
forced EtOH exposure if one is trying to mimic the effects of alcohol consumption in
humans. However, in experiments where animals control their level of EtOH consumption,
it is important to monitor how much EtOH is consumed, and how much it varies across
days/subjects. The EtOH consumption/exposure level is important because proteins have
different levels of sensitivity to EtOH. For example GABA(A) receptors containing different
subunits exhibit either low EtOH (>100mM) or high EtOH (<50mM) sensitivities (Wei et al
2004; Santhakumar et al 2006; Wallner et al 2006).
Finally, one also should consider the time of day the animals consume EtOH. Mice
(and other nocturnal rodents) tend to drink the most during the early night (Brager et al
2010 [mice]; Ruby et al 2009 [hamsters]; Rosenwasser et al 2014 [rats]). However,
drinking in the morning vs evening can have distinct effects on EtOH induced behaviors
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and cellular mechanisms (Deimling and Schnell 1980; Baird 1998; Damaggio and
Gorman 2014).
Based on these and other considerations, many different drinking paradigms have
been utilized in the EtOH research field. For instance the chronic intermittent EtOH (CIE)
paradigm involves switching between periods of EtOH consumption and periods of
withdrawal in order to reliably escalate EtOH intake and overall blood alcohol
concentration levels (Becker and Lopez 2004). For our experiments, we have used two
paradigms: a single nighttime (12 h) of no-choice EtOH consumption to investigate rapid
tolerance, and daily 4 h no-choice EtOH access (starting 1 h prior to lights-off, and
continuing 3 h into the night) over different durations of drinking (7-21 days), followed by
0-6 days of EtOH withdrawal. These drinking paradigms allow the mice to control the
amount of EtOH they consume, and we have found that the inter- and intra-animal
variability is low. Using these protocols, we have investigated how EtOH affects NMDA
and GABA receptors in the SCN. To put the experiments in context, background
information on NMDA and GABA(A) receptors, how EtOH modifies their function, and
their post-translational modifiers is presented here.
NMDA Receptors
Glutamate ionotropic NMDA receptors are heterotetromeric: they all contain two
NR1 subunits plus two additional subunits, consisting of any combination of NR2A, NR2B,
NR2C, NR2D, NR3A, and NR3B subunits. Upon activation, the ion channel opens,
allowing Ca2+, sodium ions (Na+), and potassium ions (K+) to flow through the channel
(Ca2+ and Na+ generally entering and K+ ions leaving the cell). This depolarizes the
neuron, resulting in enhanced neuronal signaling. Each NMDA receptor subunit has
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unique effects on NMDA receptor conductance characteristics. For example, an NR2A
containing NMDA receptor has consistent and steady firing, whereas an NR2B containing
NMDA receptor has more sporadic, burst firing with slower decay kinetics (Cull-Candy
2004). NR2B-containing NMDA receptors remain open 10 times longer than NR2Acontaining NMDA receptors, thus allowing more depolarization and a greater increase in
intracellular Ca2+ accumulation (Cull-Candy 2004). NMDA receptors containing both
NR2A and NR2B subunits exhibit hybrid pharmacological and kinetic characteristics
(Paoletti and Neyton 2007, Tovar et al 2013). NMDA receptors containing NR3 subunits
are inactive. While the type of subunits defines the overall characteristics of the NMDA
receptor, the receptor kinetics can also be altered via post-translational modifications.
One key post-translational modification of NMDA receptors is phosphorylation.
Phosphorylation of specific NMDA receptor subunit residues can alter ion movement in
and out of the channel or change the localization of the receptor. For example
phosphorylation of NR2B tyrosine 1472 (Y1472) increases Ca2+ ion influx through the
NMDA receptor (Nakazawa et al 2001) and maintains its localization within the synaptic
active zone (Goebel et al 2005). This is due to phosphorylated Y1472 enhancing NR2B
binding with a scaffolding protein, post-synaptic density-95 (PSD-95; Roche et al 2001;
Prybylowski et al 2005; Zhang et al 2008). Upon phosphorylation of Y1472 by Fyn kinase
(Fyn; Trepanier et al 2012; Gibb et al 2011), the C-terminus of the NR2B subunit binds to
the PSD-95/Discs large/zona occludens-1 (PDZ) binding domain of PSD-95.
On the other hand, phosphorylation of serine 1480 (S1480) breaks the interaction
of the NR2B subunit with PSD-95. This leads to internalization of the NMDA receptor
followed by the receptor either recycling back to the surface or being targeted for

12

degradation via ubiquitination (Roche et al 2001; Chung et al 2004). Phosphorylation of
S1480 involves calcium/calmodulin dependent protein kinase II (CaMKII) forming a
complex with the constitutively active kinase, casein kinase 2 (CK2), to form a trimolecular complex with NR2B. This localizes CK2 to the S1480 residue, increasing CK2
phosphorylation of S1480 (Sanz-Clemente et al 2013).
EtOH and NMDA Receptors
Many studies have demonstrated that the EtOH-induced modulation of NMDA
receptors involve changes in the phosphorylation of Y1472 and S1480 of the NR2B
subunit, suggesting that this subunit is highly sensitive to the effects of EtOH (Chandler
et al 1998; Wang et al 2010; Wu et al 2010; Clapp et al 2010, Staples et al 2015).
However, there are other aspects of NMDA receptors that are affected by EtOH, and
these effects vary depending on the duration of EtOH exposure. For example, acute EtOH
inhibits NMDA receptor conductance (Roberto et al 2004), while chronic EtOH increases
NMDA signaling (Kroener et al 2012) and alters subunit composition of NMDA receptors,
with many brain regions exhibiting increases in NR2A, NR2B, and NR1 subunit
expression (Clapp et al 2010; Pian et al 2010; Wu et al 2010; Wang et al 2011; Staples
et al 2015). Even though the expression of most NMDA receptor subunits is increased
during chronic EtOH exposure, some studies suggest EtOH has preferential effects for
the NR2B subunit. For example, in the hippocampus, a 15 minute (min) exposure to
100mM EtOH induces H-ras mediated endocytosis of NR2A subunits and increases the
ratio of NR2B to NR2A subunit containing NMDA receptors (Suvarna et al 2005). Also,
transgenic mice with a conditional knockout of the NR2B subunit do not develop
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enhanced neuronal firing in response to chronic EtOH application to the bed nucleus of
the stria terminalis (Wills et al 2012).
Ethanol and post-translational modifiers of NMDA receptors
EtOH alters the posttranslational modifications of NMDA receptors largely by
altering the activity of kinases and phosphatases that target key residues of NMDA
receptors (Barria and Malinow 2005; Prybylowski et al 2005; Honse et al 2003; Suvarna
et al 2005). Acute vs. chronic EtOH appears to have differential effects on kinases that
phosphorylate NMDA receptors (Xu et al 2006; Kash et al 2009; Chung et al 2004).
Unfortunately, direct comparisons are difficult because few studies have compared EtOH
modulation of these proteins across multiple EtOH exposure paradigms. With this caveat
in mind, in this section we focus mainly on EtOH’s modulation of Fyn kinase, CaMKII, and
striatal enriched tyrosine receptor phosphatase-61 (STEP-61).
Fyn phosphorylates Y1472 of the NMDA receptor NR2B subunit. Before this can
occur, Fyn must be phosphorylated at its tyrosine 420 (Y420) residue in response to
mature BDNF activating TrkB (Yamada and Nabeshima 2004; Carreño et al 2011).
Neuronal cell adhesion molecule-1 (NCAM-1), a neuronal cell adhesion molecule that
regulates synaptogenesis, can also activate Fyn via interactions with receptor-like protein
tyrosine phosphatase α (RPTPα, Bodrikov et al 2005). Acute and chronic exposure to
EtOH do not alter total Fyn protein expression in the hippocampus and striatum (Wu et al
2010; Darcq et al 2014), but chronic EtOH increases Y420 phosphorylation through
inactivation of STEP-61 in the dorsal medial striatum (Darcq et al 2014). EtOH can alter
expression of BDNF and TrkB, but the effects are regionally specific, with some regions
exhibiting increases in BDNF and TrkB while others have decreases (Davis 2008).
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Chronic EtOH also decreases polysialic acid (PSA) containing NCAM-1, which allows for
Fyn activation due to PSA blocking NCAM-1 related cell signals (Barker et al 2012).
CaMKIIα, another kinase important for NMDA receptor regulation, forms a complex
with CK2, allowing for increased phosphorylation of NR2B serine 1480 (S1480).
Activation of CaMKII involves increases in calcium influx, causing autophosphorylation of
CaMKIIα at threonine 286 (T286) (Davies et al 2007). This also causes
autophosphorylation of threonine 305 (T305), which reduces activation of CaMKIIα
(Colbran 1993; Zhang et al 2005). A recent study has demonstrated that phosphorylation
of CaMKIIα at T286 is associated with acute EtOH-induced increases in c-fos expression,
suggesting CaMKIIα activation is important for EtOH-related increases in neuronal firing
(Schöpf et al 2015). Also chronic ethanol increases T286 phosphorylation, but no
changes were noted in CaMKII expression in the amygdala during chronic EtOH or EtOH
withdrawal (Christian et al 2012). Because CaMKIIα activation via T286 phosphorylation
correlates with increases in neuronal activity in the SCN (Kon et al 2014) and many other
regions, EtOH-induced changes in CaMKIIα T286 phosphorylation could underlie some
of its actions on the SCN circadian clock.
STEP-61 decreases phosphorylation of NR2B Y1472. This reduces activation of
the NMDA receptor and ultimately leads to receptor internalization. Recent studies have
shown that proteosomal degradation of STEP-61 occurs through PSD-95 and BDNF,
which target STEP-61 for ubiquitin induced degradation (Won et al 2016; Saavedra et al
2016). Protein kinase A (PKA) also blocks STEP-61 from interacting with its substrates
by phosphorylating its serine 221 (S221) residue (Paul et al 2000). Studies have
demonstrated that chronic EtOH does not alter total STEP-61 expression, but does
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increase phosphorylation at the serine 221 residue, again reducing STEP-61
dephosphorylation of NMDA receptors (Darcq et al 2014). Thus, chronic EtOH could
increase NMDA receptor activity in part by decreasing activation of STEP-61.
GABA receptors
As mentioned earlier, many actions of EtOH involve changes in GABA related
signals. GABA(A) receptors are pentameric with multiple combinations of receptor subunit
types generating up to 19 different GABA(A) receptor isoforms. The most common
receptor isoforms include 2 α subunits, 2 β subunits, and either a γ or δ subunit (Olsen
and Sieghart 2008). The α and β subunits are important for regulating ion channel
conductance properties, while the γ and δ subunits regulate the localization of GABA
receptors in and out of the synaptic active zone. Activation of GABA(A) receptors that
contain γ subunits, which are typically localized within the synapse, causes phasic
inhibitory currents in neurons (Farrant and Nusser 2005), while δ subunit-containing
GABA(A) receptors, which generate tonic inhibitory currents, are typically found in
extrasynaptic regions. Another important distinction is that δ subunit-containing GABA(A)
receptors have a much higher sensitivity to EtOH than γ subunit-containing GABA(A)
receptors (Wei et al 2004; Santhakumar et al 2006; Wallner et al 2006). Because
activating GABA(A) receptors increases Cl- conductance, GABA signaling is generally
inhibitory, decreasing the signaling of its post-synaptic targets.
Regulation of GABA(A) receptors, like NMDA receptors, occurs through a series
of post-translational modifications to key residues. The PKA and protein kinase C (PKC)
kinases are well documented regulators of GABA(A) receptors via phosphorylation of
specific residues, particularly on the α4 subunit. By phosphorylating serine 408 and serine
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409 of the GABA(A) β3 subunit, PKA decreases synaptic α4 synaptic expression but
increases extrasynaptic α4 expression (Bohnsack et al 2016). Conversely, PKCγ
increases synaptic α4 expression via phosphorylation of the serine 443 residue
(Abramian et al 2010). PKC can also stimulate internalization of α4 containing GABA(A)
receptors by phosphorylating the β2 subunit (Bright and Smart 2013). Thus regulation of
GABA(A) receptor function occurs via modulation of posttranslational modifiers leading
to changes in channel flux, localization to the synaptic or extrasynaptic regions, and
subunit composition of the receptor.
EtOH and GABA receptors
EtOH alters GABA signaling, and its actions at GABA(A) receptors differ
depending on the duration of EtOH exposure in the same manner as seen with NMDA
receptors. Acute EtOH’s actions on GABA(A) receptors are subunit specific. For example,
EtOH enhances influx of Cl- ions through γ subunit-containing GABA(A) receptors (Allan
and Harris, 1986; Suzdak et al., 1986; Ticku et al., 1986; Wei et al 2004; Olsen et al 2007)
while decreasing tonic currents mediated by δ subunit-containing GABA(A) receptors
(Liang et al 2007). The effects of chronic EtOH compared to acute EtOH on GABA(A)
receptors are more complex. For instance chronic EtOH reduces the expression of
particular GABA(A) subunits, alters their phosphorylation, and leads to internalization of
GABA(A) subunits, particularly those receptors containing α1, β1, and γ subunits (Kumar
et al 2003; Liang et al 2007; Abramian et al 2010; Ron and Messing 2013). In contrast,
chronic EtOH lasting at least 40 days of exposure increases α4 and δ subunit mRNA
expression in the hippocampus (Matthews et al 1998; Cagetti et al 2004). In short, acute
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EtOH enhances actions of γ containing and inhibits δ containing GABA(A) receptors,
while chronic EtOH inhibits γ containing and enhances δ containing GABA(A) receptors.
EtOH and post translational modifiers of GABA(A) receptors
Acute and chronic EtOH can also modify the function of kinases that phosphorylate
GABA(A) receptor subunits. Acute EtOH-induced changes in kinase activity alters
receptor activation and membrane localization (Brandon et al 2000; Brandon et al 2003;
Carlson et al 2013; Carlson et al 2014; Choi et al 2008; Kumar et al 2010). The PKC
family of kinases in particular are implicated in EtOH effects on GABA(A) receptors
(Wallace et al 2006; Bowers et al 1999). PKCγ is required for ethanol induced increases
in the surface localization of α4 subunits in cerebral cortical neurons, but the specific
mechanism of interaction through which PKCγ affects GABA(A) α4 subunits is still
unknown (Werner et al 2011). Recent research has suggested chronic EtOH influences
PKCγ phosphorylation of α4 subunit serine 443, increasing α4 subunit surface localization
(Werner et al 2016 referring to Abramian et al 2010). Thus acute and chronic EtOH
induced modulation of GABA(A) receptors may involve modulation at the α4 subunit via
EtOH’s actions on PKCγ.
Other studies have suggested that EtOH alters regulation of GABA(A) α4 subunits
by PKA and not PKC. Support for this comes from studies showing that acute EtOH
activates both PKA and PKC (Dohrman et al 1996; Messing et al 1991). Further support
for this comes from studies confirming acute EtOH induced modulation of α4 trafficking
after concurrent activation of PKC and PKA (Kumar et al 2012; Carlson et al 2013).
Furthermore, a recent study has shown that direct activation of PKA and not PKC
increases the surface localization and tonic current of α4/δ GABA(A) receptors, while 4 h
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of ethanol exposure reduces α4/δ receptor abundance (Carlson et al 2016). Thus EtOH
appears to modulate localization of α4/δ GABA(A) receptors through multiple
mechanisms.
It is possible that the mixed results on PKA and PKC modulation of α4/δ GABA(A)
receptors are due to different durations of EtOH exposure, with acute EtOH mediating the
effects of α4/δ via PKA (evident by Carlson et al 2016) and chronic EtOH mediating the
effects of α4/δ via PKC (evident by Werner et al 2016). As indicated earlier, acute vs
chronic EtOH exposure differentially regulates receptor currents and subunit composition,
and can also differentially affect kinases and phosphatases. Therefore, investigating
changes in PKA and PKC associated with different forms of EtOH tolerance may be
worthwhile.
EtOH tolerance
EtOH tolerance is defined as requiring higher concentrations of EtOH to achieve
the same effect. Tolerance includes changes at the behavioral level, termed behavioral
tolerance, as well as cellular changes, termed physiological tolerance (Chandler et al
1998). Behavioral tolerance to EtOH involves the effects of EtOH across many brain
regions, as demonstrated in experiments assessing whether behavioral modifications
normally induced by EtOH (e.g. loss of coordination) are changed after continued EtOH
exposure (Grieve and Littleton 1979; Pietrzykowsky and Triestman 2008). Physiological
tolerance typically refers to the effects of EtOH tolerance on peripheral mechanisms (e.g.,
metabolism) and/or how cellular/molecular components of neurons in specific brain
regions are modified during continued exposure. Physiological and behavioral EtOH
tolerance develops over multiple time domains in mammals, including minutes (acute
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tolerance), hours (rapid tolerance), and days (chronic tolerance). Acute tolerance has
been shown to involve changes in NMDA receptor and GABA(A) receptor related
currents. For example, while initial exposure of CA1 hippocampal tissue to EtOH reduces
isolated field potentials from NMDA receptors, this effect decreases with continued
exposure over 15 minutes (Grover et al 1994). Also EtOH potentiation of GABA(A)
currents diminishes after 5-60 minutes of EtOH exposure in cell cultures prepared from
the cerebellum (Allan and Harris 1987).
Rapid tolerance, the least studied of the three forms, has been proposed to
underlie the transition from acute to chronic tolerance (Khanna et al 1991a). Most
experiments have focused on the involvement of NMDA and GABA(A) receptors in
behavioral rapid tolerance and have not addressed physiological rapid tolerance.
Pharmacologically, blocking NMDA receptors with the selective antagonist, MK-801,
blocks behavioral rapid tolerance to EtOH (Khanna et al 1991b; 1993). Muscimol, a
GABA(A) agonist, also blocks behavioral rapid tolerance to EtOH (Barbosa and Morato
2001). Unfortunately, literature investigating the cellular effects underlying physiological
rapid tolerance to EtOH is sparse.
Many studies have demonstrated changes to NMDA and GABA(A) currents during
chronic tolerance to alcohol. As mentioned, changes in expression and phosphorylation
of NMDA receptors and GABA receptors have been reported in chronic tolerance and
chronic EtOH (Wu et al 2010; Kroener et al, 2012; Honse et al 2003; Suvarna et al 2005;
Wang et al 2011; Ravindran et al 2007, Liang et al 2007, Gonzalez et al 2012, Lindemeyer
et al 2014). Chronic treatments of EtOH also cause behavioral tolerance with respect to
cognitive impairment and to the sedative effects of EtOH (Rafi-Tari et al 1996; Wu et al
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2010). Similarly, chronic tolerance has been demonstrated with respect to circadian
periodicity and locomotor activity in mice with respect to circadian regulated behaviors
(Logan et al 2012). Differences regarding cellular changes in chronic tolerance versus
other tolerance types are distinct given the changes that occur to subunit expression and
phosphorylation.
Ethanol withdrawal
The sudden withdrawal from EtOH after sustained EtOH exposure induces drastic
changes in behavior and physiology that can lead to symptoms like insomnia,
psychomotor

agitation,

hallucination,

and

delirium

tremens

(Schuckit

2014).

Experimentally in animals, the effects of EtOH withdrawal are typically studied during the
first 1-2 days, which corresponds to when the more intense behavioral and physiological
effects of EtOH withdrawal occur (Schuckit 2015). This is not to suggest that the effects
of withdrawal last only during this timeframe. Some studies have used longer periods of
EtOH abstinence that can extend from one week to several weeks. These studies are
often performed to determine the duration of EtOH withdrawal induced effects as well as
investigate novel effects across longer durations of withdrawal. For example Ding et al
2013 determined that the increased presynaptic glutamate release that develops during
EtOH exposure lasts 7 days after withdrawal.
Studies have demonstrated that EtOH withdrawal is associated with increases in
extracellular glutamate in various brain regions (Ding et al 2013; Griffin et al 2014). Some
have suggested this is due to increased presynaptic release of glutamate that develops
during chronic EtOH exposure (Roberto et al 2004; Christian et al 2013). Additionally,
physiological and behavioral changes exhibited during EtOH withdrawal are blocked by
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glutamate receptor antagonists, suggesting increased activation of glutamate receptors
occurs during EtOH withdrawal (Faingold et al 2000; Farook et al 2008). The overt effects
of sudden abstinence from EtOH are likely due in part to the inability of glutamate signals
to immediately revert to pre-EtOH exposure levels following withdrawal.
The effects of EtOH withdrawal also involve GABA receptors. Changes seen
during withdrawal include increases in GABA(A) receptor expression in the nucleus
accumbens (Linsenbardt & Boehm 2010). A study investigating the basolateral amygdala
demonstrated that surface expression of the α4 and γ2 subunits increase after 2 days of
withdrawal following chronic intermittent ethanol, while expression of α1, α2, and δ
subunits decrease (Lindmeyer et al 2014). Also, the GABA(A) agonist lorazepam reduces
handling-induced convulsions that occur after repeated EtOH withdrawals, suggesting
that enhancing GABA(A) activity during EtOH withdrawal can diminish withdrawal related
pathologies (Veatch and Becker 2005). Thus GABA(A) receptors are a strong candidate
for investigating and comparing changes in tolerance and withdrawal to EtOH.

Studying ethanol tolerance and withdrawal-induced sensitization in the SCN
circadian clock
Ethanol disrupts circadian clock function
Because circadian rhythms regulate sleep, and alcohol disrupts sleep, we and
others hypothesized that alcohol-induced disruptions in sleep are at least partially due to
disturbances in circadian regulation (Brower 2001; Prosser et al 2003; Åkerstedt 2003;
Chokroverty 2010; Rosenwasser 2010). Because persistent sleep problems after EtOH
withdrawal are a strong predictor of relapse drinking (Brower and Perron 2010; Hasler et
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al 2010), a better understanding of how EtOH affects sleep could lead to improved
treatment for AUD. Over the past 15 years substantial evidence has accumulated
showing that EtOH affects circadian rhythms and, conversely, that the circadian clock
affects EtOH consumption.
Ethanol disrupts many aspects of circadian regulation. For instance, EtOH alters
mRNA levels of the core clock genes Period1, Period2, and Period3 (Per1, Per2, and
Per3) in adolescent and adult rats (Chen et al 2004; 2006). On the other hand, mutation
of core clock genes contributes to AUD, EtOH abuse, and relapse. Mutating the Per2
gene in mice reduces expression of the glutamate transporter, Eaat1, leading to
increased extracellular glutamate and increased EtOH consumption (Spanagel et al
2005a). Another study demonstrated that both Per1 and Per2 mutant mice have
increased drinking and alcohol seeking behaviors (Gamsby et al 2013). In the same
study, Per1 mutants had higher blood alcohol levels than controls 1 h after a single
administration of EtOH, suggesting altering clock genes disrupts EtOH metabolism
(Gamsby et al 2013). Mice selectively bred for high or low EtOH consumption also have
modified core clock gene mRNA expression (Rosenwasser et al 2005; McCulley et al
2013). Thus clock genes have a role in EtOH consumption and EtOH metabolism, while
EtOH disrupts clock gene expression.
Human studies have demonstrated more links between circadian disruptions and
EtOH. Patients with AUD have a high prevalence of depression. Treating circadian
disruption with anti-depressants can reverse circadian abnormalities (Duncan 1996),
suggesting AUD and circadian disorders involve disruptions to similar neuronal circuits.
Abstinent alcoholics have disruptions of circadian patterning, in that activity patterns tend
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to be disorganized with greater effects seen in more severe cases of EtOH withdrawal
(Sano et al 1994). Studies assessing mRNA levels of clock genes (Clock1, Bmal1, Per1,
Per2, Cry1, and Cry2) from peripheral blood mononuclear cells from AUD patients
revealed decreased mRNA expression of all of these genes compared to controls (Huang
et al 2010). Mutations in the CLOCK and Per2 genes in humans are also linked to
alcoholism (Spanagel et al 2005b; Sjoholm et al 2010). Studies assessing the effects of
AUD on free-running rhythms and phase resetting in humans, however, have not been
conducted. Thus researchers have turned to animal models to investigate these effects.
Many studies have demonstrated EtOH modulation of free-running clocks and
phase resetting in animal models. For instance EtOH consumption disrupts SCN
circadian clock free-running period and phase resetting in rodents (Lindsay et al 2014
Brager et al 2010; Ruby et al 2009; Seggio et al 2009; Rosenwasser et al 2005). Research
with Drosophila melanogaster yields similar results with respect to EtOH induced
disruptions in clock periodicity (Seggio et al 2012; Ahmad et al 2013). Other rodent studies
have shown that drinking during the night versus during the day can increase EtOH
withdrawal induced fatality incidences, alter body temperature, and reduce activity,
suggesting that the timing of EtOH consumption has differing effects on the SCN
(Damaggio and Gorman 2014; Deimling and Schnell 1980; Baird 1998). With respect to
phase resetting, our in vitro experiments in mice show direct actions of EtOH within the
SCN, including EtOH inhibition of glutamate phase resetting, enhancement of
serotonergic phase resetting, and involvement of both TrkB and δ-subunit containing
GABA(A) receptors in these effects (Prosser et al 2008; Brager et al 2011; McElroy et al
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2009). Although these studies demonstrate acute EtOH actions in the SCN, a critical
characteristic of AUD is the development of tolerance.
In the SCN, tolerance is evident as decreased EtOH inhibition of photic/glutamate
phase shifts (Prosser and Glass 2009; Lindsay et al 2014; Brager et al 2010). The SCN
exhibits all three forms of tolerance: acute, rapid, and chronic, as well as withdrawalassociated glutamate hypersensitivity as indicated in this research (Prosser and Glass
2009; Lindsay et al 2014a; Lindsay et al 2014b; Lindsay et al 2014c). However, the distinct
cellular mechanisms underlying each of these conditions are not known. In our studies
we have determined how long it takes for rapid vs. chronic tolerance and withdrawal to
develop, and have identified distinct changes in NMDA subunit and GABA(A) subunit
expression, phosphorylation, and surface expression that occur during EtOH tolerance
and withdrawal hypersensitivity. We choose to focus on effects on NMDA and GABA(A)
receptors due to the fact that these receptors are key targets of EtOH and they are key
regulators of SCN circadian clock functioning. From this, we hope to gain a better
understanding of the mechanisms associated with each form of EtOH tolerance so that
we may identify key alterations in neuronal function that are necessary for each individual
tolerance mechanism.
In our experimental model we assess cellular changes across EtOH tolerance and
withdrawal hypersensitization and focus particularly on differences in the developmental
timing of EtOH tolerance and withdrawal induced sensitization. Moreover, our
assessments are conducted at key time points across the day [Zeitgeber time (ZT) 6,
ZT16, and ZT23; Zetigeber time is based on the light-dark cycle, with ZT0 being lights-on
and ZT12 being lights-off in the animal colony.] when baseline neuronal activity differs in
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the SCN and when glutamate has distinct effects. At ZT 6, when neuronal activity is
highest, glutamate does not modulate clock phase. At ZT 16, when neuronal activity is
nearing its trough, glutamate delays clock phase. AT ZT 23, when neuronal activity is
starting to rise, glutamate phase-advances the SCN clock. Using the SCN, we 1)
investigate EtOH tolerance and withdrawal physiologically via assessing glutamateinduced phase resetting; 2) assess changes in receptors and their key regulators across
these different states; and 3) compare differences in these EtOH consumption-induced
changes across distinct baseline cellular states within a single brain area. We
hypothesized that EtOH tolerance and withdrawal induced sensitization are associated
with changes in the expression and phosphorylation state of NR2B containing NMDA
receptors in the SCN, and that the extent that these changes occur differs across the
tolerance and withdrawal paradigms.

Summary of introduction
The expression of EtOH tolerance and withdrawal symptoms are two criteria for the
diagnosis of an AUD. The cellular mechanisms associated with EtOH tolerance and
withdrawal hypersensitivity are not well understood. Furthermore, little if any research has
attempted to compare cellular changes associated with different durations of EtOH use
and withdrawal. We use the SCN, the locus of the primary circadian oscillator, to study
different types of tolerance using glutamate induced phase shifts as our experimental
output. This model was chosen because photic phase shifts depend upon NMDA
receptors and are modulated by GABA(A) receptor activation (Mintz et al 1999; Ralph
and Menaker 1989; Gillespie et al. 1997; Herzog et al 2017), and EtOH modifies these
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receptors as well as the kinases and phosphatases that regulate their function. Thus
using glutamatergic phase shifts as an experimental output should constitute an excellent
indicator of changes in neuronal physiology due to EtOH tolerance and EtOH withdrawal.
We also investigate the changes that occur with respect to NMDA receptor subunit
expression, phosphorylation, and localization by comparing tolerance and withdrawal
induced sensitization in a single experiment. We planned to perform similar experiments
investigating GABA(A) receptors, but were unable due to time constraints. The literature
demonstrates that there are changes associated with acute and chronic EtOH. However,
there is little known about how these receptors mediate tolerance, and how their
regulation is variably altered by different forms of tolerance and withdrawal induced
sensitization. Thus, we will investigate different forms of tolerance and withdrawal
sensitization to EtOH in the SCN via photic phase shifts, and assess which cellular
mechanisms associated with different forms of tolerance and withdrawal induced
sensitization are distinct.
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Figure 1.1 The transcription translation feedback loop (TTFL) maintains the timing of
circadian rhythms in the majority of mammalian cells. (A) At the beginning of the day
CLOCK and Bmal1 heterodimerize and translocate into the nucleus of the cell. This
complex activates transcription of many genes including period (Per) and cryptochrome
(Cry). As the day progresses, Per and Cry mRNA become translated into proteins. Once
the PER and CRY proteins become phosphorylated, PER and CRY heterodimerize and
translocate to the nucleus. The PER:CRY complex then inhibits function of CLOCK and
Bmal1. (B) As the day ends and night begins, the transcriptional activation by
CLOCK:Bmal1 is greatly reduced by the feedback inhibition of PER:CRY. Because of
this, protein and mRNA levels decrease over the remainder of the night, which decreases
the inhibitory feedback, allowing for another cycle of transcription to begin the next day
(blue arrows).
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Chapter 2
The Mammalian Circadian Clock in the Suprachiasmatic Nucleus Exhibits Rapid
Tolerance to Ethanol In Vivo and In Vitro
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This chapter is adapted for dissertation formatting from the following publication:
Lindsay, J. H., J. D. Glass, M. Amicarelli, and R. A. Prosser (2014). The mammalian
circadian clockin the suprachiasmatic nucleus exhibits rapid tolerance to ethanol in vivo
and in vitro. Alcoholism, Clinical and Experimental Research 38 (3), 760-769.
My primary contributions to this paper were in the following areas (excluding in vivo data
that was provided by members of Dr. Glass’ research team): designing the experiments,
performing experimental procedures, collecting and analyzing data, interpreting data,
preparing the figures and writing the manuscript.

Abstract
Background
Ethanol (EtOH) triggers cellular adaptations that induce tolerance in many brain
areas, including the suprachiasmatic nucleus (SCN), the site of the master circadian
clock. EtOH inhibits light-induced phase shifts in the SCN in vivo and glutamate-induced
phase shifts in vitro. The in vitro phase shifts develop acute tolerance to EtOH, occurring
within minutes of initial exposure, while the in vivo phase shifts exhibit no evidence of
chronic tolerance. An intermediate form, rapid tolerance, is not well studied but may
predict subsequent chronic tolerance. Here, we investigated rapid tolerance in the SCN
clock.
Methods
Adult C57BL/6 mice were provided 15% EtOH or water for one 12-hour lights-off
period. For in vitro experiments, SCN-containing brain slices were prepared in the
morning and treated for 10 minutes with glutamate +/− EtOH the following night. Single-
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cell neuronal firing rates were recorded extracellularly during the subsequent day to
determine SCN clock phase. For in vivo experiments, mice receiving EtOH 24 hours
previously were exposed to a 30-minute light pulse immediately preceded by
intraperitoneal saline or 2 g/kg EtOH injection. Mice were then placed in constant
darkness and their phase-shifting responses measured.
Results
In vitro, the SCN clock from EtOH-exposed mice exhibited rapid tolerance, with a
10-fold increase in EtOH needed to inhibit glutamate-induced phase shifts. Co-application
of brain-derived neurotrophic factor prevented EtOH inhibition, consistent with
experiments using EtOH-naïve mice. Rapid tolerance lasts 48 to 96 hours, depending on
whether assessing in vitro phase advances or phase delays. Similarly, in vivo, prior EtOH
consumption prevented EtOH's acute blockade of photic phase delays. Finally,
immunoblot experiments showed no changes in SCN glutamate receptor subunit (NR2B)
expression or phosphorylation in response to rapid tolerance induction.
Conclusions
The SCN circadian clock develops rapid tolerance to EtOH as assessed both in
vivo and in vitro, and the tolerance lasts for several days. These data demonstrate the
utility of the circadian system as a model for investigating cellular mechanisms through
which EtOH acts in the brain.

Introduction
Alcohol abuse is a debilitating condition linked to depression, sleep disorders, and
cognitive defects (Brower 2001; Hesselbrock 1991; Sullivan and Pfefferbaum 2005).
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Neurochemically, alcohol affects multiple neurotransmitter systems, including GABA and
glutamate signaling (Ariwodola and Weiner 2004; Carta et al 2003; Hanchar et al 2005;
Wu et al 2010; Zhu and Lovinger 2006). However, ethanol's (EtOH's) effects can exhibit
tolerance, or desensitization, as assessed behaviorally (e.g., ataxia and hypothermia;
Crabbe et al 1979; Gill and Deitrich 1998) and electrophysiologically (Knott et al 2002).
For example, acute tolerance occurs within minutes of exposure to EtOH, while chronic
tolerance to EtOH develops over weeks to months (Khanna et al 1991). Not surprisingly,
the cellular mechanisms underlying these 2 forms of tolerance appear to be different
(Grobin et al 1998; Roberto et al 2006).
Intermediate to these is rapid tolerance, a less-studied phenomenon that develops 8 to
24 hours after initial exposure to EtOH. This form of tolerance is seen with hypnotic,
motor, and hypothermic effects of EtOH (Gilliam 1989; Silveri and Spear 1999). While
rapid tolerance may be a predictor of subsequent chronic tolerance development (Khanna
et al 1991; Radcliffe et al 2006; Wu et al 2001), little is known about its prevalence or
cellular basis.
The suprachiasmatic nucleus (SCN) circadian clock is the master 24-hour
oscillator that regulates daily behavioral and physiological rhythms in mammals. External
cues, particularly light, synchronize the SCN clock to the cyclic environment. Disruptions
in clock synchronization are linked to diverse clinical conditions, including sleep disorders,
diabetes, and cancer (Blask et al 2003; Crowley 2011; Dauchy et al 1999; Dijk et al 2000;
Stevens 2006). As alcohol abuse is associated with chronic sleep problems and other
pathologies

(Åkerstedt 2003;

Anstey

et al 2009;

Brower 2001;

Grewal

and

Viswanathen 2012; Riley et al 2011), it is important to understand the neurophysiological
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mechanisms through which EtOH affects circadian clock phase regulation. In this regard,
we and others have shown that EtOH disrupts circadian rhythms through actions within
and outside the SCN (Prosser and Glass 2009; Rosenwasser et al 2005; Spanagel
et al 2005). For example, acute EtOH administered peripherally or via microdialysis into
the SCN inhibits photic phase shifts in vivo (Brager et al 2011), while EtOH applied to the
SCN in vitro inhibits glutamate-induced phase resetting (Prosser et al 2008). Likewise,
chronic EtOH consumption inhibits photic phase shifts in vivo (Brager et al 2010).
Interestingly, the similar inhibition of SCN photic phase resetting seen with both
acute and chronic EtOH in vivo suggests that the circadian system does not develop
chronic tolerance to EtOH. This contrasts with our findings regarding acute tolerance in
vitro: the SCN develops acute tolerance within 5 to 15 minutes of initial EtOH exposure,
as exhibited by a loss of EtOH inhibition of glutamatergic phase resetting (Prosser and
Glass 2009). To further explore EtOH tolerance within the SCN and better understand the
differences between the in vivo and in vitro conditions, we investigated rapid tolerance to
EtOH using both in vivo and in vitro approaches in the mouse.

Materials and methods
Animals
Adult (~8 weeks old) male C57BL/6 mice were obtained from Harlan Laboratories
(Frederick, MD) and Jackson Laboratories (Bar Harbor, ME). Animals were singly housed
in polycarbonate cages under a 12:12 light/dark (LD) cycle at a light intensity of 270 lux,
in a temperature-controlled vivarium (23°C) with food and water provided ad libitum. The
experiments followed the National Institutes of Health Guidelines for the Care and Use of
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Laboratory Animals and were approved by the University of Tennessee Institutional
Animal Care and Use Committee and Kent State University Institutional Animal Care and
Use Committee.
EtOH consumption
Mice were trained to drink water from drip-resistant sipping tubes (Medical
Associates, Inc., St. Albans, VT) for 2 days prior to introducing EtOH. On the first day of
the experiment, the water bottle of each “EtOH-exposed” mouse was replaced with one
containing 15% EtOH immediately prior to lights-off. Mice were then allowed to consume
alcohol overnight. Control (“EtOH-naïve”) mice had their water bottles replaced with ones
containing water. Although we did not monitor the pattern of EtOH/water consumption,
our previous studies indicate that mice do the majority of their drinking (EtOH and/or
water) in the first half of the night (Brager et al 2010). The following morning at lights-on,
the amount of EtOH (or water) consumed overnight was measured, and the animals were
weighed.
Brain slice preparation
Coronal brain slices (500 μ) containing the SCN were prepared from EtOHexposed or EtOH-naïve mice between Zeitgeber Time (ZT) 0 and ZT 4 (where ZT
0 = lights-on and ZT 12 = lights-off in the animal colony) and maintained in a Hatton-style
perfusion chamber that received a continuous supply of 95% O2/5% CO2. SCN brain
slices were perfused continuously with 37°C, oxygenated, glucose/bicarbonatesupplemented Earle's balanced salt solution (EBSS), pH 7.4.
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In vitro drug treatments
Drugs, dissolved in EBSS, were bath applied to the brain slices at ZT 16 or ZT 23
(i.e., either 4 or 11 hours after lights-off in the previous LD cycle). Drug treatments were
applied by stopping the perfusion and replacing the medium in the chamber with EBSS
containing the drug treatment. After 10 minutes, the solution was removed and perfusion
restarted. Thus, for EtOH-exposed mice, the in vitro drug treatment occurred
approximately 24 to 30 hours after the bulk of their EtOH consumption and at a minimum
16 hours after their last exposure to EtOH. Drugs used in the study include glutamate
(Sigma-Aldrich, St. Louis, MO), EtOH (Decon Laboratories, Inc., King of Prussia, PA),
and brain-derived neurotrophic factor (BDNF) (Alomone Labs, HarHotzuim, Jerusalem,
Israel).
Electrophysiology
SCN neuronal activity was recorded extracellularly on day 2 in vitro using glass
microelectrodes. Electrophysiological recordings and analysis were performed with a
DataWave system (Berthold, CO). Individual cells were recorded for 5 minutes, and 4 to
6 neurons were recorded each hour. As in previous studies (Prosser 2003; Prosser and
Glass 2009; Prosser et al 2008), the firing rates of individual neurons were combined to
generate 2-hour running averages. The time of peak activity was determined by visual
estimation to the nearest quarter hour (Prosser 2003; Prosser and Glass 2009; Prosser
et al 2008). Phase shifts were calculated as the difference in time of peak of untreated
slices from the time of peak of drug-treated slices, because the process of exchanging
the medium in itself has no effect on the neuronal activity rhythm (Prosser 2003; Prosser
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and Glass 2009; Prosser et al 2008). The overall experimental design is illustrated in
Figure 2.1.
Rapid tolerance duration
To determine the duration of rapid tolerance, EtOH-exposed mice received 15%
EtOH for 1 night as usual. The next morning, the EtOH was replaced with water. Mice
had free access to water for an additional 24, 48, or 72 hours before brain slices were
prepared (Figure 2.1). Therefore, in these experiments, the in vitro drug treatments were
applied to the brain slices 48, 72, or 96 hours after the bulk of their EtOH consumption,
respectively. Brain slice preparation, in vitro drug treatment, and electrophysiological
recordings were performed as described previously.
Immunoblots
SCN brain slices were prepared from either EtOH-naïve or EtOH-exposed mice,
and drug treatments were performed at ZT 16. Immediately following the drug treatment,
slices were collected and frozen on dry ice, then stored at −80°C until protein assays were
performed. Protein was extracted from SCN tissue in ice-cold lysis buffer containing 20%
radioimmunoprecipitation assay (RIPA) buffer. Protein concentrations were determined
using a Bradford assay. Whole cell lysate was added in 40 μg quantities into acrylamide
gels for separation via SDS PAGE. Separated proteins were transferred to polyvinylidene
difluoride blots and blocked with 5% nonfat dried milk in Tris-buffered saline containing
20% Tween (TBST) for 1 hour at room temperature. Blots were exposed to NR2B
(1:1,000; EMD Millipore, Billerica, MA), actin (1:1,000; Santa Cruz Biotechnology, Dallas,
TX), NR2B p1472 (1:1,000; EMD Millipore), or NR2B p1303 (1:1,000; EMD Millipore) antirabbit polyclonal primary antibodies for 2 hours at room temperature or overnight at 4°C.
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Blots were washed 3 times with TBST and then exposed to horseradish peroxidaseconjugated goat anti-rabbit IgG secondary antibodies. After 90 minutes, blots were rinsed,
luminol solution was applied, and blots were developed using X-ray film exposed to
chemiluminescent reaction. Blots were analyzed by determining band intensity relative to
background using ImageJ (NIH, Bethesda, MD). All treatments were normalized to actin.
Significance was determined using 1-way analysis of variance (ANOVA).
In vivo assessment of rapid tolerance to EtOH
Mice housed under 12:12 LD conditions were individually caged and their general
locomotor activity rhythms were measured over a 2-week pre-experimentation period
using overhead passive infrared motion detectors interfaced with a data acquisition
system (Clocklab; Coulbourn Instruments, Whitehall, PA). As in previous studies (Brager
et al 2010), activity data were collected in 1-minute bins; activity onset associated with
lights-off (ZT 12) was defined by the initial 6-minute period that (i) coincided with an
intensity of activity that exceeded 10% of the maximum rate for the day; (ii) was preceded
by at least 4 hours of activity quiescence; and (iii) was followed by at least 60 minutes of
sustained activity. Phase shifts were calculated as the difference in projected times of
activity onset of baseline entrainment and days following EtOH-photic treatment as
determined by (i) back extrapolation of the least-squares line through activity onsets on
days 3 to 7 after EtOH-photic treatment and (ii) extrapolation of the least-squares line
calculated from activity onset data collected the last 5 days of baseline entrainment
(Brager et al 2010; Ruby et al 2009). Mice had access to EtOH during a single night as
described earlier. The subsequent night, animals received an intraperitoneal (i.p.)
injection of EtOH (2.0 g/kg, v/v in physiological saline) or saline alone immediately
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preceding a 30-minute phase-delaying light pulse (25 lux) delivered from ZT 16 to 16.5.
Immediately following the light pulse, the animals were released into constant darkness
(DD) for 2 weeks to assess the extent of phase-delaying using an Aschoff Type II
procedure (Pittendrigh and Daan 1976). Under DD, activity onset is designated as
circadian time 12 and is the phase reference point for the onset of the subjective night.
Statistical analysis
Differences in the time of peak neuronal activity were assessed using 1-way
ANOVA. In vivo results were analyzed using a standard t-test. In all cases, the level of
significance was set at p < 0.05.

Results
EtOH consumption
Across all the experiments, mice given access to 15% EtOH drank 2.19 ± 0.06 ml
of EtOH, which translates to an average consumption of 10.6 g/kg ± 0.32 EtOH (n = 112).
The SCN circadian clock exhibits rapid tolerance to in vitro EtOH: neuronal activity
rhythms
We have shown that in vitro glutamate treatment at ZT 16 delays the phase of the
SCN neuronal activity rhythm by about 3 hours (Prosser et al 2008). Here, we confirm
these results, showing that a 10-minute bath application of glutamate (1 mM) at ZT 16 to
brain slices prepared from an EtOH-naïve mouse induced a 3-hour phase delay
(Figure 2.2B) relative to the time of peak activity for an untreated slice (Figure 2.2A).
Again, as previously demonstrated (Prosser et al 2008) in brain slices from EtOH-naïve
mice, treatment with 1 mM glutamate + 20 mM EtOH inhibited the glutamate-induced
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phase delay (Figure 2.2C). In slices from EtOH-exposed mice, in vitro glutamate
treatment continued to induce a 3-hour phase delay (Figure 2.2E); however, 20 mM EtOH
did not block glutamate-induced phase delays in tissue prepared from EtOH-exposed
mice. Instead, glutamate continued to induce a 3-hour phase delay (Figure 2.2D). The
mean phase shifts induced by these treatments are summarized in Figure 2.2E. Because
this loss of EtOH inhibition was seen approximately 24 hours after EtOH consumption,
these results are consistent with the induction of rapid tolerance to EtOH.
Next, we investigated rapid tolerance with respect to glutamate-induced phase
advances. As shown previously (Prosser et al 2008), bath application of glutamate
(1 mM) at ZT 23 to SCN slices induced a 3-hour phase advance. Treating brain slices
from EtOH-naïve mice with 20 mM EtOH in conjunction with glutamate inhibited phase
advances (mean phase shift = 0.0 ± 0.0 hours, n = 2). However, 20 mM EtOH did not
inhibit glutamate-induced phase advances in tissue from EtOH-exposed mice
(Figure 2.3). Thus, our results with treatments at ZT 23 are consistent with those seen
with ZT 16 treatments.
The SCN circadian clock exhibits rapid tolerance to EtOH in vivo: behavioral rhythms
In EtOH-exposed mice, a systemic injection of saline followed by a 30-minute light
pulse delivered at ZT 16 induced a 0.62 ± 0.17 hour (n = 7) phase delay in the behavioral
activity rhythms (Figure 2.4A). Previously, we have shown that systemic administration of
2 g/kg EtOH to EtOH-naïve mice decreases photic-induced phase delays by about 50%
(Brager et al 2011). However, this same dose of EtOH administered to EtOH-exposed
mice did not significantly inhibit light-induced phase delays in behavioral activity (mean
phase delay = 0.86 ± 0.13 hours [n = 7], p = 0.29 vs. saline injection; Figure 2.4B). Thus,
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the rapid tolerance observed in our SCN brain slices is also seen with photic phase shifts
of behavioral activity rhythms in intact animals.
Dose-dependency of EtOH inhibition
We have shown that in vitro EtOH inhibits glutamate-induced phase delays in
EtOH-naïve mice with an ED50 of about 10 mM (Prosser et al 2008). Here, we
investigated whether rapid tolerance to EtOH involves a complete loss of sensitivity to
EtOH or just a decrease in sensitivity. Thus, we treated SCN brain slices prepared from
EtOH-exposed mice with 1 mM glutamate at ZT 16 together with varying concentrations
of EtOH. As seen in Figure 2.5A, the amount of EtOH needed to completely inhibit
glutamatergic phase delays increased from 20 to 200 mM, with an ED50 between 150 and
175 mM (Figure 2.5A). A similar shift is seen in the dose–response curve for EtOH
treatments at ZT 23. Application of 200 mM EtOH completely blocked glutamatergic
phase advances, with the ED50 again between 150 and 175 mM (Figure 2.5B).
BDNF reverses EtOH inhibition of glutamatergic phase shifts
We have shown that co-treatment of BDNF with glutamate and EtOH prevents
acute EtOH inhibition of glutamate-induced phase shifts in tissue prepared from EtOHnaïve mice (Prosser et al 2008). Here, we investigated if this occurs in tissue prepared
from EtOH-exposed mice. First, we repeated our previous experiments with brain slices
from EtOH-naïve mice at ZT 16, showing that co-application of 100 ng/ml BDNF with
1 mM glutamate and 20 mM EtOH resulted in phase delays of 2.3 ± 0.45 hours, n = 3
(Figure 2.2E), indicating that BDNF blocked EtOH inhibition. Next, we tested brain slices
from EtOH-exposed mice, applying 100 ng/ml BDNF together with 200 mM EtOH and
1 mM glutamate. BDNF rescued glutamate-induced phase delays in brain slices from
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EtOH-exposed mice as well (Figure 2.2E). Control experiments indicated that applying
EtOH and BDNF together in the absence of glutamate did not induce phase shifts
(Figure 2.2E). [Previous work indicates that BDNF and EtOH applied separately do not
induce phase shifts (Mou et al 2009; Prosser et al 2008)]. We also investigated these
treatments at ZT 23. Similar to our results at ZT 16, adding 100ng/mL BDNF rescued
glutamate-induced phase advances blocked by 200 mM EtOH, resulting in a
2.7 ± 0.15 hour phase advance (n = 3) (Figure 2.3). Again, control experiments confirmed
that EtOH and BDNF did not induce phase shifts when applied concurrently (Figure 2.3).
Thus, BDNF reverses EtOH inhibition of in vitro glutamate-induced phase shifts in brain
slices from both EtOH-naïve and EtOH-exposed mice.
Duration of rapid tolerance
To determine how long rapid tolerance to EtOH persists in the SCN, we modified
the experimental protocol by expanding the time between in vivo EtOH consumption and
brain slice preparation. Thus, brain slices were prepared 24, 48, or 72 hours after access
to EtOH ended. These brain slices were then treated with EtOH + glutamate the
subsequent subjective night at either ZT 16 or ZT 23, as in previous experiments. Thus,
for brain slices prepared 24 hours after EtOH access ended, ZT 16 treatments were
applied approximately 48 hours after the majority of EtOH consumption, while for slices
prepared 48 hours after EtOH access ended, ZT 16 treatments were applied
approximately 72 hours after the majority of EtOH consumption. Given this time frame,
co-treatment with glutamate and EtOH 48 hours after the majority of EtOH consumption
resulted in phase delays of 3.2 ± 0.14 hours, n = 3, indicating continued tolerance, while
co-treatment with glutamate and EtOH 72 hours after the bulk of EtOH consumption
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resulted in no significant phase delay (0.45 ± 0.07 hours, n = 3; Figure 2.6A). Thus, rapid
tolerance to EtOH inhibition of glutamate-induced phase delays is lost between 48 and
72 hours after the majority of EtOH consumption. With respect to ZT 23 experiments, the
tolerance to EtOH appears to last longer. Phase advances were seen after coadministration of EtOH and glutamate 48 and 72 hours after EtOH consumption, (mean
phase shifts = 2.875 ± 2.04 hours, n = 2 and 3.1 ± 0.29 hours, n = 3, respectively) but not
when they were co-applied approximately 96 hours after EtOH consumption ended (mean
phase shift = 0.0 ± 0.20 hours, n = 3) (Figure 2.6B). Thus, for glutamate-induced phase
advances, rapid tolerance to EtOH appears to last between 72 and 96 hours after EtOH
consumption.
Effects of EtOH on NR2B expression and phosphorylation
Our data suggest that SCN tissue develops tolerance to EtOH at both ZT 16 and
ZT 23. To begin investigating potential cellular mechanisms underlying this effect, we
focused on N-methyl-D-aspartate (NMDA) receptors in the SCN. Using immunoblot
analysis, we first focused on EtOH-naïve SCN tissue. Tissue samples were probed for
total NR2B and Y1472-phosphorylated NR2B receptor levels. Blot analysis showed that
in EtOH-naïve tissue neither total NR2B expression nor Y1472-phosphorylated NR2B
expression were significantly altered by any of the treatments when compared to control
(n = 5, p > 0.966) (Figure 2.7A). Next, we probed for the expression of total NR2B along
with NR2B phosphorylated at either Y1472 or S1303 in EtOH-exposed tissue. Y1472 and
S1303 are phosphorylated by Src family proteins and CAM kinase II, respectively.
Analysis again revealed no significant differences across treatments (n = 3, p > 0.711)
(Figure 2.7B). Thus, we found no differences in the level of total NR2B expression in the
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SCN or in the level of NR2B phosphorylation at Y1472 and S1303 in EtOH-naïve and
EtOH-exposed tissue.

Discussion
The SCN clock exhibits rapid tolerance to EtOH
Chronic alcohol abuse is characterized by a self-perpetuating spiral of decreasing
alcohol sensitivity and increasing consumption (Kalant 1998). A better understanding of
the cellular processes underlying alcohol desensitization may help to develop treatments
that alleviate or prevent this debilitating cycle of dependence. The propensity to develop
rapid tolerance has been linked to the development of chronic tolerance (Khanna
et al 1991). Here, we show for the first time that the SCN circadian clock exhibits rapid
tolerance to EtOH. Importantly, this tolerance is seen in vivo as well as in vitro. Rapid
tolerance in the SCN in vitro is manifest as a 10-fold shift in the dose–response curve for
EtOH inhibition of glutamate-induced phase-advance and phase-delay shifts; it is
apparent 24 hours after initial exposure to EtOH; and it lasts for several days. Future
experiments could determine whether rapid tolerance in vivo exhibits similar
characteristics by increasing the concentration of EtOH administered i.p. and by
increasing the time interval between EtOH consumption and testing for EtOH inhibition of
photic phase shifts.
Time course of rapid tolerance
We have previously shown that EtOH inhibits in vitro glutamate-induced phase
delays and phase advances and that the SCN clock develops an acute form of tolerance
to EtOH within 5 to 15 minutes (Prosser and Glass 2009). This acute tolerance does not
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dissipate with maintained EtOH application for at least 3 hours. That study did not
determine the duration of acute tolerance after EtOH removal, but a previous report
indicates that acute tolerance is lost 24 hours after EtOH exposure (Allen and Harris,
1987). This time course, in part, helps to differentiate acute tolerance from rapid
tolerance.
Rapid tolerance develops more slowly than acute tolerance, being initially seen 8
to 24 hours after exposure (Crabbe et al 1979; Kalant 1998). In this study, our
experimental design precludes an accurate estimation of the time course of tolerance
development, because we utilized self-administration of EtOH by the mice over the course
of a 12-hour lights-off period, and we did not monitor the timing of EtOH consumption.
The minimum time between EtOH consumption and when EtOH was applied to the brain
slices (or administered to the mice in vivo) was 16 hours. However, based on typical
nocturnal drinking patterns in mice (Brager et al 2010), the actual time between the 2
EtOH exposures was likely closer to 24 hours. To more narrowly define the time course
of tolerance development, the time of EtOH access by the mice would have to be further
restricted.
An issue not previously addressed in the literature is the persistence of rapid
tolerance. We investigated this issue with both early night phase delays and late night
phase advances. For glutamate/EtOH treatments at ZT 16, we found that tolerance lasts
at least 48 hours after EtOH exposure but is no longer present after 72 hours. As the
experiment requires tolerance assessment at times when glutamate phase shifts the
circadian clock, we are limited in our ability to define the time course more precisely.
Interestingly, rapid tolerance appears to last between 72 and 96 hours for ZT 23 co-
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treatments with glutamate and EtOH. This difference in time course may be related to the
distinct cellular mechanisms associated with circadian clock phase delays and phase
advances (Gillette and Mitchell 2002). Determining differences in the cellular responses
to alcohol through phase delay/advance mechanisms could provide key information on
how alcohol affects neuronal cellular dynamics, especially those associated with the
development of tolerance.
BDNF reverses EtOH inhibition of glutamatergic phase shifts in EtOH-exposed mice
In these experiments, rapid tolerance in the SCN was characterized by a lack of
response to the lower (20 mM) concentration of EtOH, while a 10-fold higher
concentration was able to inhibit glutamate-induced phase shifts. This higher EtOH
concentration could potentially affect different cellular mechanisms than the lower
concentrations: many studies have demonstrated dose-dependent differences in receptor
sensitivity to EtOH, including GABA (Wakita et al 2012; Wu et al 2005) and glutamate
(Allgaier 2002; Blevins et al 1997; Proctor et al 2006) receptors. Our previous
experiments demonstrated that BDNF prevents acute EtOH inhibition of glutamateinduced phase shifts (Prosser et al 2008), suggesting that EtOH acts in part by inhibiting
BDNF actions. Therefore, as an initial assessment of potential differences in cellular
mechanisms, in these experiments, we investigated whether the inhibition induced by
200 mM EtOH likewise was sensitive to reversal by BDNF. Our results show that BDNF
still reverses EtOH inhibition during rapid tolerance, suggesting that similar cell signaling
processes underlie EtOH's actions under both conditions.
As application of BDNF can enhance NMDA receptor activity, it is possible that
rapid tolerance in the SCN involves changes in either NMDA (glutamate) or TrkB (BDNF)
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receptors. Previous studies determined that NMDA receptor antagonists can prevent
rapid tolerance (Khanna et al., 1991). Others indicate that NMDA receptors, especially its
NR2B subunit, play a major role in the onset of tolerance (Yaka et al., 2003). Both acute
and chronic EtOH exposure can alter NMDA receptor biochemistry by decreasing
phosphorylation at the Y1472 residue (Wu et al 2010), but whether similar changes occur
with rapid tolerance is not known. We hypothesized that rapid tolerance could involve
either increased NR2B expression and/or enhanced phosphorylation at NR2B Y1472
residue. However, our data do not support this hypothesis. There are several possible
explanations: First, it is possible that the changes underlying rapid tolerance do not
include changes in NR2B expression and phosphorylation. If true, this would differentiate
rapid tolerance from both acute and chronic tolerance (Läck et al 2005; Miyakawa
et al 1997; Nagy 2008; Roberto et al 2006; Trepanier et al 2012). Second, rapid tolerance
may involve compensatory responses upstream and/or downstream of NMDA receptors.
For example, chronic EtOH induces increases in striatal enriched tyrosine phosphatase33 (STEP-33) and p38 mitogen activated protein kinase (MAPK), without altering Src,
Lyn, and Fyn kinases (Wu et al 2010). It may be worthwhile investigating these molecules
in future experiments with rapid tolerance. Third, changes in NMDA receptor membrane
localization could play a role in rapid tolerance. Future experiments using biotinylation
could begin to address this possibility. Last, rapid tolerance may involve other receptors,
such as TrkB or GABA(A) receptors that are known to play critical roles in the SCN. For
example, BDNF enhances NMDA currents in the SCN (Kim et al 2006), so rapid tolerance
could involve an increase in TrkB signaling. Also, a previous study found that EtOH acts
in the SCN at least partially through activating GABA receptors (McElroy et al 2009).
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Therefore, it will be important to determine whether rapid tolerance is associated with
decreases in GABA signaling in the SCN. Importantly, due to the different durations of
rapid tolerance, we observed regarding glutamate-induced phase delays and phase
advances, it will be important to assess these cellular mechanisms with respect to phase
advances in addition to phase delays.

Summary: the different manifestations of EtOH tolerance
Broadly speaking, to better understand the mechanisms leading to alcohol abuse,
it is important to clarify the different forms of tolerance at the behavioral, physiological,
and molecular levels. Acute EtOH exposure is associated with transient changes in
receptor signaling, whereas chronic EtOH exposure leads to changes in receptor
expression and localization, and intracellular signaling processes. Rapid tolerance lies
somewhere in between, and its relationship with the other 2 forms of tolerance is uncertain
(Lovinger and Roberto 2013). Although we have shown that acute tolerance develops in
vitro (Prosser and Glass 2009) determining whether it occurs in vivo is technically difficult.
Rapid tolerance, we show here, occurs both in vitro and in vivo with respect to EtOH
modulation of the SCN circadian clock. Interestingly, our previous research indicates that
chronic tolerance may not develop in vivo (Brager et al 2010). However, results from
another study suggest the lack of chronic tolerance seen in our experiments may be due
to using no-choice EtOH versus free-choice EtOH drinking (Seggio et al 2009). In light of
reports suggesting that developing rapid tolerance correlates with the propensity to
develop chronic tolerance (Khanna et al 1991; Radcliffe et al 2006; Wu et al 2001), the
possible lack of chronic tolerance in vivo is surprising. There could be compensatory
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changes outside the SCN that counteract a decrease in circadian clock sensitivity to
chronic EtOH, or the SCN circadian clock could somehow be immune to chronic EtOH
tolerance. We should be able to distinguish between these possibilities in our in vitro
preparation by investigating whether chronic tolerance is seen in SCN brain slices. It will
also be interesting to investigate potential differences in cellular changes depending on
the mode of EtOH administration.

Significance
Rapid tolerance to EtOH has been linked to the development of chronic tolerance,
a critical step toward alcohol dependency and abuse (Khanna et al 1991; Radcliffe
et al 2006; Wu et al 2001). Therefore, determining the physiological and molecular
characteristics that differentiate the forms of EtOH tolerance should help elucidate the
processes that lead to alcohol abuse, and possibly identify treatments that could prevent
that progression. Our demonstration that rapid tolerance is seen with the SCN circadian
system at the cellular and behavioral levels through the use of complementary in vivo and
in vitro experimental paradigms further proves its usefulness for investigating the direct
connections between cellular actions of EtOH and its behavioral manifestations.
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Figure 2.1 In vitro rapid tolerance experimental protocol. On Day 1, mice are allowed
overnight access to 15% ethanol (EtOH). At lights-on of Day 2, mice are sacrificed and
suprachiasmatic nucleus (SCN) brain slices are prepared. At Zeitgeber Time (ZT) 16 or
ZT 23, brain slices receive drug treatment. After 10 minutes, drug treatment is removed,
and slices are left undisturbed until the next day. On Day 3, electrophysiological
recordings of SCN neuronal activity are conducted. For tolerance duration experiments,
an additional 1 to 3 days of water-only access were added to the protocol between the
single night of EtOH access and when brain slices were prepared.
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Figure 2.2 Rapid tolerance to ethanol (EtOH) inhibition of glutamate-induced phase
delays. Shown are the 2-hour mean ± SEM of suprachiasmatic nucleus neuronal activity
obtained in individual experiments. (A) Control experiment with no drug treatment
showing normal time of peak activity at Zeitgeber Time 6 (ZT 6). (B) A 10-min bath
application of glutamate (1 mM) at ZT 16 to brain slices prepared from an EtOH-naïve
mouse induces a 3-hour phase delay. (C) Treating brain slices from an EtOH-naïve
mouse with 1 mM glutamate + 20 mM EtOH leads to no shift, indicating that the
glutamate-induced phase delay is inhibited. (D) The 20 mM EtOH does not block
glutamate-induced phase delays in brain slices prepared from an EtOH-exposed mouse.
Horizontal bars: time of lights-off in the animal colony; vertical bars: time of drug
treatment(s); dotted line: mean time of peak in control experiments. (E) Shown are the
mean (±SEM) phase shifts induced in experiments involving various combinations of
glutamate, EtOH, and brain-derived neurotrophic factor (BDNF) bath applied at ZT 16.
EtOH inhibits glutamate-induced phase delays in brain slices from EtOH naïve mice, and
this effect is reversed by co-application of 100 ng/ml BDNF. In brain slices from EtOHexposed mice 20 mM EtOH does not block glutamate-induced phase delays, while
200 mM EtOH completely blocks glutamate-induced phase delays. Again, this inhibition
by EtOH is reversed by co-application of 100 ng/ml BDNF. Co-treatment with BDNF and
EtOH alone had no effect on brain slices from either EtOH naïve or EtOH-exposed mice.
One-way ANOVA indicated a significant effect of treatment, F(29) = 14.4. *Post hoc
(Holm-Sidak) test indicates p < 0.001 versus control experiments.
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Figure 2.3 Rapid tolerance to ethanol (EtOH) inhibition of glutamate-induced phase
advances. Shown is a summary of mean (± SEM) phase-shifts induced in experiments
involving various combinations of glutamate, EtOH and brain-derived neurotrophic factor
(BDNF) bath applied at Zeitgeber Time 23 (ZT 23) in tissue from mice exposed to EtOH
24 hours prior to treatment. EtOH 20 mM does not inhibit glutamate-induced phase
advances. However, raising the concentration to 200 mM EtOH inhibits glutamateinduced phase advances. This effect is reversed by co-application of 100 ng/ml BDNF.
*p < 0.001 vs. controls, post hoc (Holm-Sidak) test.
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Figure 2.4 Rapid tolerance to inhibition of photic phase shifts in vivo. (A) Representative
double-plotted actograms of general locomotor activity showing the effects of systemic
injection of saline (top) and 2 g/kg ethanol (EtOH) (bottom). Injection was performed
immediately prior to a 30 minute light pulse at ZT 16. Black arrows represent time of drug
administration and light pulse. (B) Shown is the mean phase shift induced by a 30-minute
light pulse at ZT 16 with systemic injection of either saline or 2 g/kg EtOH prior to light
pulse in mice given access to EtOH the previous night. Bars are the mean ± SE. Phase
delays for saline (0.62 ± 0.17 hours, n = 7) and EtOH (0.86 ± 0.13 hours, n = 7) are not
significantly different (p = 0.29).
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Figure 2.5 (A) Dose–response curves for ethanol (EtOH) inhibition of glutamate-induced
phase delays in vitro in brain slices prepared from EtOH–naïve (black dots) and EtOHexposed (white triangles) mice. (Data from EtOH-naïve mice replotted from Prosser et al.
[[1]] for the ease of comparison.) (B) Dose–response curves for EtOH inhibition of
glutamate-induced phase advances in vitro in brain slices prepared from EtOH-exposed
mice. In both cases, the glutamate-induced phase shifts in brain slices from EtOHexposed mice are completely inhibited by 200 mM EtOH, with an ED50between 150 and
175 mM.
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Figure 2.6 Rapid tolerance duration for ethanol (EtOH) inhibition of glutamate-induced
with phase delays and phase advances. (A) Shown are the mean (±SEM) phase shifts
induced by co-application of 1 mM glutamate and 20 mM EtOH to brain slices prepared
from mice that consumed 15% EtOH either 24, 48, or 72 hours prior to drug treatment at
Zeitgeber Time 16 (ZT 16). Glutamate-induced phase delays are insensitive to EtOH
inhibition at 24 and 48 hours after EtOH consumption but are completely blocked by EtOH
72 hours after EtOH consumption. (B) Shown are the mean (±SEM) phase shifts induced
by co-application of 1 mM glutamate and 20 mM EtOH to brain slices prepared from mice
that consumed 15% EtOH either 24, 48, 72, or 96 hours prior to drug treatment at ZT 23.
Glutamate-induced phase advances are insensitive to EtOH inhibition at 24, 48, and
72 hours after EtOH consumption but are completely blocked by EtOH 96 hours after
EtOH consumption.
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Figure 2.7 The effects of glutamate, ethanol (EtOH), and brain-derived neurotrophic
factor (BDNF) application on N-methyl-D-aspartate receptor subunit NR2B and NR2B
phosphorylation levels in EtOH-naïve and EtOH-exposed slices. (A) NR2B subunit
expression and Y1472 residue phosphorylation levels in suprachiasmatic nucleus (SCN)
brain slices prepared from EtOH-naïve mice. The treatments are as follows: no-treatment
control (Ctl); 1 mM glutamate (Glu); 1 mM glutamate and 20 mM EtOH (Glu+EtOH); 1 mM
glutamate, 20 mM EtOH, and 100 ng/mL BDNF (Glu+EtOH+BDNF); 20 mM EtOH and
100 ng/mL BDNF (EtOH+BDNF). Each group represents 4 independent replicates. (B)
NR2B subunit expression, Y1472 residue phosphorylation, and S1303 residue
phosphorylation in SCN brain slices prepared from EtOH-exposed mice. The treatments
for EtOH-exposed slices are as follows: rapid tolerance with no treatment (RTC); EtOHnaïve with no treatment (NoEC); 1 mM glutamate (Glu); 1 mM glutamate and 20 mM
EtOH (Glu+EtOH20); 1 mM glutamate and 200 mM EtOH (Glu+EtOH200); 1 mM
glutamate, 200 mM EtOH, and 100 ng/mL BDNF (Glu+EtOH200+BDNF); 1 mM
glutamate and 100 ng/mL BDNF (Glu+BDNF). Each group represents 2 to 3 independent
replicates.
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Chapter 3
Changes in NMDA Receptor and NMDA Receptor Signaling-Associated
Characteristics During Ethanol Tolerance and Withdrawal in the Suprachiasmatic
Nucleus.
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Abstract
Alcohol tolerance and withdrawal induced effects are criteria for alcohol use
disorders listed by the DSM-V. Although tolerance and withdrawal have been studied
extensively over many decades, there is still uncertainty regarding the mechanistic
distinctions that characterize the different forms of tolerance. Gaps in the existing
literature include a lack of research on the cellular mechanisms underlying each form of
EtOH-induced change, inconsistencies in the experimental procedures investigating a
specific region across multiple studies, and not having demonstrated multiple tolerance
forms in a single brain region. The suprachiasmatic nucleus (SCN) is the primary clock
oscillator that regulates the timing of mammalian biological rhythms. Previous work has
demonstrated that ethanol (EtOH) blocks photic phase shifts. Interestingly, both acute
and rapid tolerance have been shown to develop in the SCN, with respect to EtOH
inhibition of glutamate-induced phase shifts. Here, we demonstrate using our in vitro
analysis that chronic tolerance and withdrawal induced hypersensitization to glutamate
also occur. For our drinking model investigating chronic tolerance, we allowed mice to
consume EtOH for 4 h each day, with access to 15% EtOH starting one hour prior to lights
out through three hours after lights out. Tolerance developed after 10 days of 4 h EtOH
access, as indicated by a decreased sensitivity to EtOH inhibition of glutamate-induced
phase shifts. For withdrawal, we used the 4 hour access model for 21 days followed by
two days of withdrawal. We observed an increased sensitivity to glutamate–induced
phase shifts in SCN tissue following withdrawal, consistent with withdrawal induced
hyperexcitability. Additionally, we used Western blotting to compare changes in NMDA
receptors and associated proteins across multiple forms of EtOH plasticity, including rapid
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tolerance, chronic tolerance, and EtOH withdrawal. We demonstrated an increase in
NR2B/NR2A total expression ratios after 21 days of drinking and after EtOH withdrawal,
and an increase in phosphorylation of Y1472 during withdrawal. Furthermore, we also
detected an increase in mature BDNF and p-TrkB during withdrawal. These results
demonstrate that multiple tolerance forms and withdrawal induced hypersensitization
occur in the SCN; that chronic drinking and EtOH withdrawal change the subunit
composition of NMDA receptors in the SCN; and that increases in mBDNF, TrkB
phosphorylation, and Y1472 phosphorylation occur during EtOH withdrawal. Importantly,
this study further demonstrates the power of using the SCN as a model system to
investigate EtOH induced plasticity.

Introduction
Alcohol use disorder (AUD) is a condition that develops after long periods of
ethanol (EtOH) consumption. Many studies have investigated the cellular processes
associated with AUD. However, a major complication in AUD research is that the effects
of EtOH change as one progresses from short-term to long-term drinking. The acute
effects of EtOH include inhibition of glutamate signaling and enhancement of GABA
signaling (Roberto et al 2004; Proctor et al 2006; Moykkynen and Korpi 2012; Hughes et
al 2013). As EtOH exposure increases, changes in synaptic localization, total expression,
and phosphorylation of receptor proteins occur (Hendricson et al 2004; Roberto et al
2004; Clapp et al 2010; Wu et al 2010). These effects are seen throughout the brain,
although the specific changes appear to differ regionally. Complicating the picture is that
varying EtOH exposure paradigms have been used to investigate changes in different
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brain areas, including in the suprachiasmatic nucleus (SCN) (Prosser et al 2008; Brager
et al 2010; Ruby et al 2009; Seggio et al 2009; Prosser and Glass 2009; Lindsay et al
2014; Rosenwasser et al 2014).
A critical component of the transition from social drinking to EtOH abuse is thought
to be the development of tolerance, where increasing amounts of alcohol are consumed
to achieve the same effects. Three major forms of EtOH tolerance have been described
that differ based on time after initial exposure – acute tolerance (develops 5-15 minutes
after drinking), rapid tolerance (develops 8-24 hours after drinking), and chronic tolerance
(occurs after days/weeks of ethanol exposure). For example, acute tolerance has been
measured with respect to ataxia and motor impairment (Gill and Deitrich, 1998; Ramirez
et al 2011), rapid tolerance with hypothermic and hypnotic effects (Gilliam 1989; Silveri
and Spear 1999), and chronic tolerance with circadian activity rhythms and loss of righting
reflex (Rosenwasser et al 2014; Daut et al 2015). Although the mechanisms underlying
these different forms of tolerance are still under investigation, many cellular changes have
been noted. With tolerance in general, glutamatergic and γ-aminobutyric acid (GABA)
signaling mechanisms adapt to increase and decrease baseline signaling properties,
respectively. Acute tolerance has been linked to increased expression of N-methyl-Daspartate (NMDA) receptor NR2A and NR2B subunits in the hippocampus and cortex
(Roh et al 2011). Transgenic studies also suggest a role for α1 subunits of GABA
receptors in acute tolerance (Werner et al 2006; Werner et al 2009). In two separate
studies,

applying

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic

acid

receptor

(AMPA) receptor and NMDA receptor antagonists block rapid tolerance associated with
motor coordination and hypothermic effects of ethanol (Rial et al 2009; Khanna et al
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1997). Finally, changes in total expression and phosphorylation of key residues of NMDA
receptor and GABA receptor subunits have been demonstrated during chronic EtOH
tolerance (Wu et al 2010; Kroener et al, 2012; Honse et al 2003; Suvarna et al 2005;
Wang et al 2011; Ravindran et al 2007, Liang et al 2007, Gonzalez et al 2012, Lindemeyer
et al 2014). Ethanol withdrawal following chronic exposure is typically characterized by
insomnia, psychomotor agitation, hallucination, and delirium tremens (Schuckit 2014). At
the cellular level, withdrawal induces dramatic changes in glutamate and GABA signaling
(Clapp et al 2010; Reynolds et al 2015; Kumar et al 2009; Carlson et al 2016).
In summary, the cellular mechanisms associated with acute, rapid, and chronic
EtOH tolerance, and EtOH withdrawal appear to differ (Grobin et al 1998; Radcliffe et al
2006; Roberto et al 2006; Ward et al 2009; Clapp et al 2010: Lindsay et al 2014; Tran et
al 2015). However, rarely have the cellular mechanisms underlying each of these forms
of EtOH-induced plasticity been assessed in a single study or in a single brain region.
Thus our goal was to assess changes in the SCN across multiple forms of EtOH tolerance
and EtOH withdrawal.
We use the SCN circadian clock as a model system to investigate EtOH. The
circadian clock in the SCN is the primary endogenous oscillator that regulates daily
rhythms in behavior and physiology in mammals. External cues such as light phase-shift
the circadian clock in order to maintain proper synchrony with the environment. Lightinduced phase resetting in the SCN clock requires NMDA receptor activation (Ding et al
1997; Mintz et al 1999; Wang et al 2008). Numerous studies have shown that EtOH
disrupts the ability of the SCN clock to respond to synchronizing cues such as light. For
example, EtOH administration alters circadian clock period in vivo, and inhibits photic
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phase resetting in rodents acutely in vivo (Prosser and Glass 2009; Ruby et al 2009),
acutely in vitro (Prosser et al 2008; Prosser and Glass 2009), and chronically in vivo
(Rosenwasser et al 2005; Seggio et al 2007; Ruby et al 2009; Seggio et al 2009; Brager
et al 2010). Because EtOH is known to disrupt NMDA receptor function across a variety
of exposure paradigms, we chose NMDA receptors as our primary focus for these
experiments. Previously we showed that acute and rapid tolerance to EtOH occur in the
SCN in mice (Prosser and Glass 2009; Lindsay et al 2014). Here we expand upon these
studies,

showing

that

chronic

tolerance

and

withdrawal-induced

glutamate

hypersensitivity also develop in the SCN in vitro, and these EtOH-induced changes are
each accompanied by distinct changes in specific parameters of NMDA receptor
expression.

Materials and methods
Mice
Adult (~8 week old) C57BL/6 adult male mice were obtained from Harlan
Laboratories (Frederick, MD). Mice were individually housed in polycarbonate cages
under a 12:12 light/dark (LD) cycle, with food and water available ad libitum unless
otherwise noted. The experiments followed the National Institution of Health Guidelines
for the Care and Use of Laboratory Animals and were approved by the University of
Tennessee Knoxville Institutional Animal Care and Use Committee. In all experiments,
mice were allowed access to either water or 15% EtOH from drip-resistant sipping tubes
(Medical Associates, Inc., St. Albans, VT).
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Brain slice preparation, and drinking schedules
A rapid tolerance drinking schedule was performed as described in Lindsay et al
2014. Briefly, mice had their water bottle replaced with one containing a 15% EtOH/water
solution for a single 12 h lights-off period. At lights-on following EtOH access, the volume
of EtOH consumed and the weight of the mouse was recorded. Afterwards, 500 um
coronal brain slices containing the SCN were prepared for electrophysiological recording
or for Western blot assays. Brain slices were maintained at 37°C in an interface style
brain slice chamber and perfused with Earle’s balanced salt solution (EBSS), pH 7.4,
supplemented with 95% O2/5% CO2, sodium bicarbonate, glucose and gentamicin.
To investigate chronic tolerance, a 4h/day drinking protocol was used. This
involved exchanging the water bottles with ones containing a 15% EtOH/water solution
beginning one hour prior to lights off and continuing through 3 hours after lights off, for a
total of 4 hours. EtOH and water consumption and body weight of each mouse was
measured daily. The 4h EtOH access protocol continued for 10-21 days depending on
the exact experiment. At lights-on after the last day of drinking, coronal brain slices
containing the SCN were prepared and maintained as described above.
For EtOH withdrawal, mice underwent the chronic drinking protocol for up to 21
days followed by 2-6 days with no EtOH access (food and water were available adlibitum). At lights-on following the withdrawal period, coronal brain slices were prepared
and maintained as described above.
Drug treatment
During the first night after brain slice preparation, SCN tissue received bath
application of drugs dissolved in EBSS at Zeitgeber time (ZT) 16 (where ZT 0 = lights-on
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and ZT 12 = lights-off in the animal colony). Drug treatments were performed by stopping
the perfusion and replacing perfusion media with EBSS containing the drug treatment for
10 minutes. Afterwards, the solution was removed and the perfusion was resumed. Drug
treatments contained a combination of glutamate (Sigma Aldrich, St. Louis, MO) and
EtOH (Decon Laboratories, Inc., King of Prussia, PA). SCN tissue used for Western blot
and biotinylation assays did not receive drug treatments but rather were collected at
Zeitgeber time (ZT) 6, 16, or 23 and stored at -80°C until protein extraction.
Electrophysiological recordings
Extracellular single-unit recordings commenced the morning of the second day in
vitro. Recordings were performed using glass microelectrodes filled with 5M NaCl as in
previous studies (Prosser 2003; Prosser et al 2008; Prosser and Glass 2009). Each cell
was recorded for 5 minutes, with at least 5 cells recorded per hour over the course of a
ten-hour period. Recordings and firing rate analysis were done using DataWave software
(Loveland, CO). The firing rates of individual neurons were combined into 2 h running
averages, and the peak in neuronal activity was assessed visually as the time of
symmetrically highest activity calculated to the nearest quarter hour (Prosser 2003;
Prosser et al 2008; Prosser and Glass 2009).
Protein extraction
SCN tissue samples were thawed, placed in RIPA lysis buffer containing 1mM Tris
pH 8.8, 5mM SDC, 5mM SDS, 1% triton, protease inhibitor cocktail (Thermo Scientific,
Waltham, MA), and phosphatase inhibitor cocktail (Thermo Scientific), and lysed using
15 sec sonication pulses. The supernatant was separated from the pellet using
centrifugation at 13000 rpm at 4°C. Protein concentrations were determined using a
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Bradford assay. The supernatant was then loaded into a 7% poly-acrylamide gel and
electrophoresis was performed. Proteins were transferred to a polyvinylidene fluoride
(PVDF) FL immobilon membrane (EMD Millipore, Billerica, MA) using the Transblot turbo
system (Bio-Rad Laboratories, Hercules, CA).
Western blot assays
Following protein extraction, Western blots were performed as reported previously
(Lindsay et al 2014). Briefly, PVDF membranes were blocked with 5% milk in TBST then
incubated with primary antibodies for 2 hours at room temperature or overnight at 4°C.
Primary antibodies used were: α-phospho-Y1472 (1:1000, EMD Millipore), α-phosphoS1480 (1:1000, AbCam, Cambridge, United Kindgdom), α-NR2B (1:1000, EMD
Millipore), α-NR1 (1:1000, AbCam), α-NR2A (1:1000, EMD Millipore), α-PSD-95 (1:2000,
EMD Millipore), α-BDNF (detects both mature and pro BDNF; 1:200, Santa Cruz
Biotechnology, Dallas, TX), α-TrkB (detects both full length and truncated TrkB; 1:200,
Santa Cruz), α-phospho-tropomyosin receptor kinase A Y680 (binds correspondingly to
Y706 of TrkB; 1:200, Santa Cruz), and α-Actin HRP conjugate (Santa Cruz
Biotechnology, Dallas, TX). After rinsing, blots were exposed to secondary antibodies of
goat α-Rabbit (Vector Laboratories, Burlingame, CA), goat α-Mouse (Vector
Laboratories), donkey α-Rabbit (Li-COR, Lincoln, NE), or donkey α-Goat (Li-COR)
conjugated to horseradish peroxidase or infrared dye (LI-COR). Blots were allowed to
incubate for an hour and a half with secondary antibodies. Protein bands were detected
on Green x-ray film (Thermo Scientific) in experiments using chemilumenescence or
using the Imagestudio program in experiments using fluorescent dye.
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Cell surface biotinylation
SCN brain slices removed from the perfusion chamber at ZT 6, 16, or 23 were
placed in EBSS containing 1mg/mL NHS-SS-biotin (Thermo Scientific) for 75 min on ice.
The reaction was halted by addition of 1mM glycine. Slices were then rinsed with ice cold
EBSS and stored at -80°C until protein extraction. The extracted protein samples were
run through desalting columns in a centrifuge for 2 min at 4°C. Neutravidin ultralink resin
(200mL; Thermo Scientific) was added to samples and incubated overnight at 4°C. The
next day the avidin resin was separated from the flow-through via centrifugation and
collecting the supernatant (flow-through). Flow-through was kept for control purposes.
The avidin resin was then rinsed three times with lysis buffer. Sample and flow-through
were boiled for 5 minutes at 100°C. Samples and flow-through were loaded into polyacrylamide gels. Protein samples were then transferred to PVDF after separation of
proteins on the gel, and Western blot assays were performed as described above.
Statistical methods
All statistical analysis was performed using SigmaPlot. Individual mice were experimental
units for electrophysiological recordings. Tissue from a single mouse (or pooled samples
when necessary) were the experimental unit for Western blots and biotinylation
experiments. Post-hoc Holm-Sidak analysis using t-test or ANOVA was used between
two comparisons or among multiple comparisons for each experiment, respectively.
Significance was considered when P < 0.05.
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Results
EtOH consumption across multiple treatments
Mice allowed to consume EtOH for a single 12 h lights-off period had an average
EtOH consumption of 10.62 ± 0.32 g/kg, n=112. Mice given 4 h of daily access to EtOH
for 10 days had an average daily EtOH consumption of 3.36 ± 0.23 g/kg/day, n=93. Mice
given 4 h of daily access to EtOH for 21 days had an average daily EtOH consumption of
2.52 ± 0.24 g/kg/day, n=29. Because all experiments assessed SCN tissue that had been
maintained in vitro for a minimum of 4 h, we did not measure blood alcohol levels in the
mice.
Chronic tolerance to EtOH occurs in the SCN
In brain slices prepared from EtOH naïve mice, firing rates normally peak at ZT6
(Figure 3.1A). The mean time of peak in control slices occurred at 6.1±0.30 n=3, which is
consistent with previous research (e.g., Prosser et al 2008). Glutamate applied at ZT16
to SCN slices from EtOH naïve mice induces a phase delay of ~3 hours (Figure 3.1B),
which is inhibited by co-application of 20 mM EtOH (Figure 3.1C,).
Brain slices prepared from mice that had undergone 4hr EtOH daily consumption
for 10 days exhibited no difference in the time of peak neuronal activity compared to brain
slices prepared from EtOH naïve mice (difference in time-of-peak vs. tissue from EtOHnaïve mice = -0.77 ± 0.37 n=3, Figure 3.1 E). Likewise, applying 1 mM glutamate alone
at ZT16 to brain slices from these mice induced a phase delay of ~3 hours (Figure 3.1E),
consistent with the effects seen in brain slices from EtOH naïve mice. However, as seen
in Figure 3.1D, co-applying 20mM EtOH and 1mM glutamate to brain slices prepared from
these mice did not inhibit the glutamate-induced phase shifts. However, increasing the
concentration of EtOH co-applied with 1mM glutamate to 200 mM completely blocked the
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glutamate-induced phase shifts in brain slices prepared from the 10-day EtOH drinking
mice (-0.42 ± 0.30, n=3 Figure 3.1E). Thus 4 hr daily consumption of EtOH for 10 days
decreased EtOH inhibition of in vitro glutamate-induced phase resetting, consistent with
the development of chronic tolerance. To more carefully assess the change in EtOH
sensitivity that occurs with this drinking paradigm, we tested the ability of an intermediate
concentration of EtOH (150 mM) to inhibit glutamate-induced phase shifts. As seen in
Figure 3.1E 150 mM EtOH was also unable to inhibit glutamate-induced phase shifts in
brain slices prepared from these mice.
Next we investigated how many days of EtOH drinking are needed to induce
chronic tolerance. As shown in Figure 3.1F 20mM EtOH continued to inhibit glutamateinduced phase shifts in brain slices after mice had undergone up to 7 days of chronic
drinking, but not in brain slices from mice that had consumed EtOH for 8 or more days.
Thus, at least 8 days of drinking EtOH is needed to generate chronic tolerance as
assessed under these conditions.
Sensitization to glutamate develops in the SCN during 2 days of withdrawal from EtOH
Next we investigated the effects of EtOH withdrawal on the SCN circadian clock.
In this case, we assessed changes in the sensitivity of the SCN circadian clock to
glutamate induced phase shifts. First we generated a dose response curve for glutamateinduced phase delays in brain slices from EtOH naïve mice. There was an abrupt shift
from no phase-shifting response with 1uM glutamate to a maximum ~ 3 h phase delay
with 10 uM glutamate (Figure 3.2A). In contrast, 1uM glutamate applied to SCN brain
slices from mice that had undergone EtOH drinking for 21 days followed by 2 days of
withdrawal induced significant phase shifts of nearly 3 h (2.42 ± 0.36 hrs, n=3) (Figure
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3.2A). A similar phase-shift was induced by 10 uM glutamate applied to SCN tissue under
these conditions, indicating that EtOH withdrawal leads to a change in dose
responsiveness and not a change in the amplitude of the phase-shifting response.
To assess whether this change in glutamate sensitivity was the result of EtOH
withdrawal or if it was due to the prior EtOH consumption, we investigated the phaseshifting effects of glutamate applied to brain slices prepared from mice having undergone
21 days of ethanol consumption without subsequent EtOH withdrawal. As summarized in
Figure 3.2A, not only was 1uM glutamate unable to induce phase shifts in these brain
slices, but a higher (100 uM) concentration of glut was required to induce a phase delay.
Thus, prior to EtOH withdrawal, the SCN clock appears to be slightly less sensitive to
glutamate-induced phase shifts while glutamate hypersensitivity develops during the
period of EtOH withdrawal.
To clarify the duration of EtOH consumption needed to generate the withdrawalassociated glutamate hypersensitivity, we varied the number of days of EtOH
consumption prior to the 2 days of withdrawal. As summarized in Figure 3.2B, withdrawalinduced glutamate hypersensitivity was seen after 17 or 21 days of chronic EtOH, but not
after 10 or 14 days. Additionally, we clarified the duration of glutamate hypersensitivity
after withdrawal. Withdrawal induced glutamate hypersensitivity still occurs after 4 days
but not after 6 days of EtOH withdrawal (Figure 3.2C). Thus the duration of withdrawal
associated hypersensitivity lasts between 4-6 days after sudden EtOH abstinence.
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EtOH-induced

changes

in

NR2A:NR2B

ratio,

NR2B

phosphorylation,

and

upstream/downstream NMDA regulators
Previously, we determined that total expression of the NMDA receptor subtype 2
(NR2B) subunit and phosphorylation of the tyrosine 1472 (Y1472) residue of the NR2B
subunit do not change during rapid tolerance (Lindsay et al 2014). Here we expanded our
investigation of potential changes in NMDA receptors and related proteins in response to
varying EtOH exposure and withdrawal paradigms. A summary of the proteins we
assessed and our results is provided in Table 3.1. We performed Western blot assays on
SCN tissue from EtOH naïve mice, and from mice receiving 1 night of drinking, 10 days
or 21 days of 4-hr/day drinking, and 21 days of drinking followed by 2 days of withdrawal.
As seen in Figure 3.3 A and B, no significant changes were observed with respect to total
NR2A or NR2B subunit expression in SCN tissue across any of the 5 conditions.
However, the ratio of NR2B/NR2A expression was significantly higher after 21 days of
drinking with or without 2 days of withdrawal when compared to SCN tissue from naïve
mice (21 days: 3.67 ± 0.84 n=7, t4=3.50 p=0.015; withdrawal 3.45 ± 0.57 n=7, t4=3.232,
p=0.027; Figure 3.3C). We also tested total expression of the NR1 subunit, however no
changes were noted (1 ± 0.00 control, 1.21 ± 0.17 overnight, 1.09 ± 0.15 10 day, 1.34 ±
0.29 21 day, 1.36 ± 0.28 withdrawal; F4=0.552, n=4 for all conditions; data not shown).
Next we investigated changes in NR2B subunit phosphorylation. Relative to EtOH
naïve SCN tissue, we found a significant increase compared to control and overnight
conditions in phosphorylation of NR2B Y1472 in SCN tissue from mice that had
experienced 21 days of chronic drinking followed by 2 days of withdrawal, but no change
in other groups (withdrawal: 4.98 ± 1.53 n=8, vs control t4=3.23, p=0.030; vs overnight
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1.02 ± 0.33 n=8, t4=3.21 p=0.028 Figure 3.4A). We also tested phosphorylation at NR2B
S1480, however no changes were noted (1 ± 0.00 control, 1.56 ± 0.39 overnight, 1.07 ±
0.23 10 day, 1.14 ± 0.38 21 day, 1.03 ± 0.33 withdrawal; F4=0.570, n=4 for all conditions
data not shown).
Phosphorylation of NMDA receptors has been linked to activation of TrkB
receptors. More specifically, TrkB phosphorylates and activates Fyn kinase (Yamada and
Nabeshima 2004; Carreño et al 2011), which leads to increased activation of NMDA
receptors via Fyn-induced phosphorylation of the NR2B subunits (Nakazawa et al 2001;
Goebel et al 2005). Binding of mature brain-derived neurotrophic factor (mBDNF)
activates TrkB, leading to phosphorylation of many residues including Y1472 of the
NMDA receptor (Mizuno et al 2003). To investigate potential upstream mechanisms
leading to changes in phosphorylation of NR2B Y1472 during tolerance and withdrawal,
we investigated changes in pro BDNF and mBDNF expression, truncated TrkB and full
length TrkB expression, and TrkB phosphorylation in SCN tissue. We found a significant
increase in mBDNF total expression during withdrawal compared to EtOH naïve controls
(withdrawal 2.07 ± 0.34, n=6, t4 =3.104, p=0.046; Figure 3.4c). Furthermore an increase
in pTrkB at Tyr 706 occurred during withdrawal compared to all other conditions
(withdrawal 2.55 ± 0.50, n=4; vs control t4 =3.401, p=0.039; vs overnight 1.13 ± 0.168 t4
=3.114, p=0.049; vs 10 day t4 =3.312, p=0.042; t4 =3.231, p=0.044 vs 21 days; Figure
3.4d). No significant changes were noted for expression of pro BDNF (1 ± 0.00 control,
1.04 ± 0.16 overnight, 1.14 ± 0.16 10 day, 1.10 ± 0.17 21 day, 1.03 ± 0.10 withdrawal;
F4=0.185, p=0.94, n=6 for all conditions, data not shown), truncated TrkB (1 ± 0.00
control, 0.95 ± 0.07 overnight, 0.80 ± 0.24 10 day, 0.84 ± 0.24 21 day, 0.95 ± 0.22
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withdrawal; F4=0.211, p=0.93, n=4 for all conditions data not shown), nor full length TrkB
(1 ± 0.00 control, 0.91 ± 0.14 overnight, 1.40 ± 0.45 10 day, 1.01 ± 0.28 21 day, 1.34 ±
0.29 withdrawal; F4=0.640, p=0.64, n=4 for all conditions, data not shown).
Lastly with respect to assessing changes in protein expression, we investigated
two additional proteins whose expression has been linked to changes in glutamate
signaling: the postsynaptic density scaffolding protein, PSD-95 and the tyrosine kinase,
Fyn (Roche et al 2001; Prybylowski et al 2005; Trepanier et al 2012; Gibb et al 2011).
However, we found no significant differences in PSD-95 (1 ± 0.00 control, 1.49 ± 0.27
overnight, 1.99 ± 0.44 10 day, 1.01 ± 0.28 21 day, 1.34 ± 0.29 withdrawal; F4=1.398,
p=0.26, n=7 for all conditions, data not shown) and Fyn (1 ± 0.00 control, 1.08 ± 0.10
overnight, 0.99 ± 0.13 10 day, 1.56 ± 0.24 21 day, 1.88 ± 0.46 withdrawal; F4=1.432,
p=0.25, n=6 for all conditions, data not shown) across all experimental conditions.
Increases in phosphorylation of Y1472 are linked to increases in synaptic
localization of NR2B containing NMDA receptor (Nakazawa et al 2001; Goebel et al
2005). To test if increases in surface localization of NR2B subunits occur during tolerance
and withdrawal, we used cell surface biotinylation. Although an increase in Y1472
phosphorylation was noted during withdrawal treatments, we observed no changes in
surface expression of NR2B subunits across all conditions (1 ± 0.00 control, 1.24 ± 0.29
overnight, 1.28 ± 0.27 10 day, 1.32 ± 0.30 21 day, 1.48 ± 0.30 withdrawal, F4=1.069 n=6,
p=0.39; data not shown).
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Discussion
Time course of chronic tolerance and withdrawal
Previously we demonstrated the SCN develops rapid tolerance after mice were
given access to EtOH for a single night, and this tolerance is characterized by a decrease
in EtOH inhibition of photic (in vivo) and glutamate-induced (in vitro) circadian clock phase
resetting (Lindsay et al 2014). Here we extend these findings to show that the SCN also
develops chronic tolerance to EtOH and withdrawal-induced glutamate hypersensitivity.
Chronic tolerance is characterized by a 10-fold right-ward shift in the dose response curve
for EtOH inhibition of glutamate induced phase delays compared to that seen in SCN
tissue from EtOH-naïve mice. This shift in sensitivity is similar to that seen previously with
rapid tolerance (Lindsay et al 2014). Conversely, EtOH withdrawal leads to a 10-fold leftward shift in the dose response curve for glutamate induced phase delays. Together with
our previous demonstration of acute EtOH tolerance in the SCN in vitro (Prosser and
Glass 2009), these results illustrate that the SCN circadian clock exhibits a high degree
of EtOH-induced plasticity in its phase-resetting properties. Given that EtOH disrupts
circadian periodicity and phase resetting (Prosser et al 2008; Prosser and Glass 2009;
Rosenwasser et al 2005; Seggio et al 2007; Seggio et al 2009; Brager et al 2010), it will
be important to determine the cellular mechanisms underlying EtOH-induced plasticity in
the SCN.
Prior to exploring changes at the cellular level, we sought to clarify the duration of
EtOH consumption necessary to develop chronic tolerance to EtOH and withdrawalinduced glutamate hypersensitivity in the SCN. Using the 4-h/day drinking paradigm
described here, we find that mice need to consume EtOH for at least 8 days to develop
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chronic tolerance. This is consistent with results from other brain regions (Broadwater et
al 2011; Matson et al 2014). In contrast, mice need more than 14 days of EtOH
consumption

to

develop

withdrawal-induced

glutamate

hypersensitivity in

our

experiments. Previous research suggests that the duration of drinking necessary to
induce withdrawal hypersensitivity varies across dose and the way EtOH is delivered. For
instance withdrawal induced convulsions can develop after as few as four days of EtOH
vapor inhalation (Olive and Becker 2008) or after 1 – 2 weeks of drinking in rodents
(Roberto et al 2004; Wang et al 2010), with the latter being consistent with the timing of
withdrawal induced glutamate sensitization seen here. Importantly, we found that chronic
EtOH drinking without withdrawal does not cause glutamate hypersensitization. Together,
the differences seen between these drinking paradigms support the hypothesis that
distinct cellular adaptations underlie the different forms of EtOH tolerance and withdrawalinduced hypersensitization to glutamate.
To our knowledge, these are the first data carefully delineating these differences
in EtOH plasticity. It will be interesting to extend these findings to other brain regions and
other EtOH exposure modalities. Doing so will help determine whether the distinctions
shown here are unique to the SCN and these drinking paradigms, or if they are more
universally applicable. Because both EtOH tolerance and withdrawal can lead to
increases in EtOH consumption (Schuckit 1994; Brown et al 1998; Bell et al 2001;
Ciccocioppo et al 2003; Das et al 2016), a better understanding of the distinct dynamic
cellular processes underlying each of these conditions may improve treatments to
alleviate or prevent development of alcohol dependence. Importantly, these data illustrate
that investigating multiple EtOH exposure paradigms in a single experiment can provide
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a more complete picture of EtOH-induced changes than using a single drinking model.
The data from this study also show the power of using the SCN circadian clock to
investigate nuanced differences in EtOH effects in the brain.
Prior results indicated that under a no-choice EtOH drinking protocol, the SCN
circadian clock in mice does not exhibit chronic tolerance with respect to EtOH inhibition
of photic phase shifts in vivo in hamsters and mice (Ruby et al 2009; Brager et al 2010).
Our data here showing chronic tolerance as assessed in vitro raise interesting questions
regarding the underlying differences. In Brager et al 2010, mice consumed substantially
higher amounts of EtOH (20g/kg/day vs. 3.36 ± 0.23 g/kg/day in the current study), and
drinking was not restricted to a 4 h period each day. In addition evidence suggests in an
in vivo study that 21 days of voluntary EtOH consumption induces no change to phase
shift conditions (Seggio et al 2009) as opposed to 21 day forced EtOH which inhibits
phase shifts (Seggio et al 2009; also as in Ruby et al 2009 and Brager et al 2010). Seggio
et al suggested the phase shifting mechanism is insensitive to chronic voluntary EtOH but
is sensitive to chronic forced EtOH. Another study by Rosenwasser et al 2014
demonstrated reduced effects of EtOH on circadian period after sustained high EtOH
intake which would be consistent with the development of chronic tolerance, but this effect
seems to differ by sex and strain. Thus the specific EtOH consumption paradigm and
model used is an important factor to consider for studying chronic EtOH tolerance in the
SCN.
Likewise, in vivo experiments investigating EtOH withdrawal induced changes in
phase shifts have shown mixed results. For instance, enhanced photic phase shifts are
seen during withdrawal in hamsters (Ruby et al, 2009), while EtOH withdrawal does not
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alter photic phase shifts in mice (Brager et al, 2010). In contrast, free-running circadian
periodicity after withdrawal from 12 days of EtOH exposure is altered in mice, suggesting
that EtOH continues to affect clock-regulated mechanisms during withdrawal in mice
(Logan et al 2012). With respect to our results, we showed that withdrawal induced
hypersensitization to glutamate occurs in the SCN in vitro. Because sensitivity to photic
phase resetting was not assessed using a range of light intensities in the in vivo
investigations mentioned above, future experiments assessing withdrawal induced
hypersensitization to light will be informative.
Another important difference is that the previous studies investigated photic phaseresetting in vivo vs. the in vitro glutamate-induced phase resetting used in the present
study. Because EtOH affects many areas that directly or indirectly modulate circadian
clock functioning, the lack of tolerance seen in vivo could reflect changes in EtOH actions
across multiple regions that counteract or obscure changes occurring in the SCN. For
example, The SCN receives serotonin (5-HT) input from the dorsal raphe nucleus that
inhibits photic phase shifts (Meyer-Bernstein and Morin 1996; Bradbury et al 1997; MeyerBernstein and Morin 1999). EtOH has been shown to modify 5-HT levels in rats,
increasing 5-HT in the hypothalamus, amygdala, and hippocampus after a 4 week liquid
diet (Ara and Bano 2015). In contrast, 5-HT levels decrease in rats after 6 hours of
withdrawal following chronic liquid diets in the cerebral cortex and striatum in one study
(Uzbay et al 1998), and the hypothalamus, amygdala, and hippocampus in another (Ara
and Bano 2015). We have shown that acute EtOH modulates serotonergic signaling in
the SCN, as seen by enhanced serotonergic phase shifts in vitro (Prosser et al 2008),
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while acute EtOH inhibits serotonergic phase shifts in vivo, likely through extra-SCN
actions (Ruby et al., 2009).
Another difference between the data shown here and the previous in vivo study is
that hypersensitivity to photic phase resetting was not seen in vivo during withdrawal
(Brager et al., 2010). Again this could be due to the methodological differences mentioned
above, or to whether the SCN clock is being investigated in vivo vs. in vitro. As with
chronic tolerance, it will be important to determine what specific difference(s) account for
the differential observance of hypersensitivity. Because the development of chronic
tolerance and withdrawal symptoms are thought to be critical steps toward alcohol
dependence and abuse (Khanna et al, 1991; Radcliffe et al 2006; Wu et al 2010), it will
be important to further explore the factors that determine whether chronic tolerance is
seen in the SCN. Importantly, identifying factor(s) that protect the circadian clock from
exhibiting chronic tolerance and withdrawal hypersensitivity in vivo could provide insight
into treatments for those dependent on alcohol.
Hyperexcitation during withdrawal has been reported across many brain regions
(see Burnett et al 2016). This effect of EtOH withdrawal was described by Finn and
Crabbe, who suggested that the adaptations that developed in order to offset the effects
of EtOH are left unopposed during withdrawal, thus leaving neurons in a hyperactive state
(1997). Withdrawal induced hyperexcitability is thought to contribute to synaptic
remodeling in the orbital frontal cortex (Badanich et al 2011). Evidence of withdrawalinduced hyperexcitation is also seen in the basal lateral amygdala (BLA), as indicated by
shortened paired-pulse ratio intervals and increased medium excitatory post-synaptic
current (mEPSC) amplitude and frequency occur during withdrawal (Lack et al 2007).
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Furthermore, differences were noted in mEPSC amplitude and frequency in the BLA
during chronic drinking versus 24 h of withdrawal (Lack et al 2007), similar to our
electrophysiological results supporting physiological disparities in chronic EtOH vs EtOH
withdrawal. Thus hypersensitivity to glutamate in the SCN during withdrawal is consistent
with hyperexcitable induced states commonly found during EtOH withdrawal in other brain
regions.
Unexpectedly, we observed that the SCN clock has a decreased sensitivity to
glutamate after 21 days of chronic drinking but prior to EtOH withdrawal. This is somewhat
paradoxical, given the glutamate hypersensitivity is seen during withdrawal. Decreased
glutamate sensitivity is also not entirely consistent with the increase in NR2B:NR2A ratio
and decrease in EtOH sensitivity we see with chronic EtOH (discussed below). We put
forth several possible explanations: 1) AMPA receptors that partially mediate the phase
shift mechanism become desensitized to glutamate and subsequently internalized during
chronic EtOH. Some reports have shown that AMPA receptors are needed for phase
shifts in the SCN (Takeuchi et al 1991; Mizoro et al 2010). Unlike NMDA receptors, AMPA
receptors become desensitized and internalized after prolonged exposure to glutamate
(Traynelis et al 2010; Alsaloum et al 2016). Due to chronic EtOH increasing the levels of
extracellular glutamate, AMPA receptors could become internalized, leading to partial
desensitization to glutamate during phase shifts as shown in Figure 3.2A. 2) Another
explanation could be through cytochrome p450, which metabolizes EtOH to
acetaldehyde. It is possible that chronic EtOH induced neurotoxicity via increases in
cytochrome p450 2e1 expression (as seen in Zhong et al 2012) causes rapid
internalization of NMDA receptors (as seen in Goto et al 2006) in the SCN. In support of
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this, one report shows decreased NMDA receptor sensitivity to glutamate in the ventral
tegmental area (VTA) after 8 weeks of chronic EtOH (Fitzgerald et al 2012). Yet these
results are somewhat counterintuitive to our results showing increases in NR2B to NR2A
ratios given that changes in these ratios promote glutamate sensitization. Perhaps this
shift in the NR2B:NR2A ratio is indicative of a shift from synaptic NMDA receptors to
extrasynaptic receptors, which is somewhat indicative of neurotoxicity (Hardingham and
Bading 2010). (Figure 3.2A) and therefore may promote a partial glutamate
desensitization in the SCN. 3) Increases in protein expression of glutamate transporters
could occur during chronic EtOH in the SCN. This change would be somewhat specific to
the SCN as other articles have reported mixed results. For instance CIE in the nucleus
accumbens increases glutamate release without altering glutamate transport (Griffin et al
2015). In the nucleus accumbens and VTA of rats, decreases in protein expression of
excitatory amino acid transporter-1 but no change in excitatory amino transporter-2 were
reported during increased glutamate release due to chronic EtOH (Ding et al 2013).
Additonally, chronic EtOH decreases glutamate transporter-1 levels in the PFC (Sari et al
2013). Increases in glutamate transporter expression during chronic EtOH could lead to
clearance of lower levels of glutamate, leading to glutamate induced phase shift
desensitization in our in vitro experiments.
As mentioned, many studies have shown increased levels of extracellular
glutamate in specific brain regions during chronic EtOH exposure (Gass and Olive, 2008;
Brage et al 2012; Ding et al 2012; Ding et al 2013; Griffin et al 2013). This is thought to
be due to chronic EtOH inhibition of presynaptic metabotropic glutamate receptors,
leading to an increase in glutamate release (Simonyi et al 2004). In contrast, recent

106

reports demonstrate that astrocytes regulate the amount and timing of extracellular
glutamate in the SCN (Brancaccio et al 2017). If chronic EtOH alters the release and/or
reuptake of glutamate in the SCN, it would be interesting to investigate whether this
involves changes in astrocytic and/or neuronal activity.
Chronic EtOH consumption increases the NR2B to NR2A ratio in the SCN
Having determined the EtOH exposure paradigms needed to induce the various
forms of EtOH-induced plasticity, we began to assess the cellular changes occurring with
each condition. We focused on NMDA receptors because their activity is necessary for
photic phase resetting in the SCN (Ding et al 1997; Mintz et al 1999; Wang et al 2008).
We determined that there is a significant increase in the ratio of NR2B to NR2A subunit
expression in the SCN after 21 days of drinking that is not seen with either rapid tolerance
or 10 days of EtOH consumption. This increase in NR2B:NR2A expression is still seen
during EtOH withdrawal. Therefore, this change in NMDA receptor subunit expression is
induced during chronic EtOH consumption, but is not necessary for the expression of
chronic tolerance, which is seen as early as after 10 days of drinking. However, the
increase in NR2B:NR2A expression could be necessary for withdrawal induced glutamate
hypersensitivity. Changes in NR2B:NR2A ratios are thought to regulate the threshold for
synaptic plasticity globally (Philpot et al 1999; Yashiro and Philpot 2008), and have been
seen following EtOH exposure. An increase in NR2B:NR2A expression was seen in
hippocampal slices 15 minutes after application of 100mM EtOH (Suvarna et al 2005),
which would correspond to an acute tolerance paradigm. In contrast, decreased
NR2B:NR2A expression is seen in rat hippocampal slices following 7 weeks of EtOH
vapor (Staples et al 2015). Others have observed that changes in NMDA receptor subunit
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composition in response to chronic EtOH are region specific (Nona et al 2014). With
respect to the SCN, an increase in NR2B:NR2A expression is consistent with an
enhanced propensity for glutamate-induced phase shifts because 1) NR2B subunits are
necessary for glutamate-induced phase shifts (Wang et al 2008) and 2) NR2B-containing
NMDA receptors have longer decay kinetics than NR2A-containing receptors (Cull-Candy
and Leszkiewicz 2004). Whether this change in NR2B:NR2A expression is necessary for
the withdrawal-induced glutamate hypersensitivity will need to be explored in subsequent
studies.
Although we did not see a change in total NR2B subunit expression during either
chronic EtOH or withdrawal, other EtOH induced changes could be affecting NMDA
receptor function. For example, chronic drinking increases membrane localization of
NR2B subunits in many regions (Qiang et al 2007). Moreover, EtOH withdrawal has been
shown to increase lateral movement of NR2B containing NMDA receptors to extrasynaptic zones (Clapp et al 2010; Wills et al 2012). Our surface biotinylation experiments
did not show changes in NR2B surface expression during tolerance nor withdrawal.
However we noticed a trend towards increased NR2B surface expression during
withdrawal (data not shown), and haven’t ruled out changes to surface expression of
NR2B subunits during chronic EtOH and withdrawal. Given this, our NR2B results for
biotinylation need further validation. In addition our experiments only investigated
changes to NR2B subunits. Thus other subunits may show changes in surface expression
during chronic EtOH and withdrawal. Also, although assessing surface expression of
receptor proteins is a better indicator of potential activity than assessing total expression,
it still does not discern synaptic vs extrasynaptic protein levels. Given that increases in
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extrasynaptic NR2B are implicated in multiple neurological diseases (Hardingham and
Bading 2010; Gladding and Raymond 2011), it would be worthwhile to investigate
potential changes in NR2B membrane localization in the SCN in response to different
EtOH exposure paradigms using synaptic fractionation.
Our results also demonstrated that the increase in the NR2B:NR2A ratio persists
following 2 days of withdrawal from EtOH. Interestingly, withdrawal after chronic EtOH
induces hyperexcitability of NMDA receptor related currents in the striatum that lasts up
to 9 days after cessation of EtOH (Wang et al 2010). In contrast, no changes in NMDA
receptor EPSCs were noted in the central amygdala after 6-8h of withdrawal following
chronic EtOH vapor inhalation (Roberto et al 2004), but NMDA receptor-related EPSCs
are increased in the BLA 24 hours after abstinence from chronic EtOH (Lack et al 2007).
Thus the duration of withdrawal induced hyperexcitability of NMDA receptor currents, and
the mechanisms underlying these changes may be region specific. To determine how
withdrawal modifies NMDA receptor related signals in the SCN, future investigations
assessing synaptic vs extrasynaptic localization of NR2B subunits should be a priority.
Increased phosphorylation of Y1472 occurs during EtOH withdrawal
In addition to changes in receptor subunit composition, NMDA receptor signaling
is modulated by phosphorylation of specific residues. For example, phosphorylation of
NR2B Y1472 potentiates NMDA receptor currents, leading to synaptic recruitment of
NMDA receptors (Nakazawa et al 2001; Goebel et al 2005). Consistent with this, we found
that during EtOH withdrawal after chronic drinking there is a significant increase in
phosphorylation of NR2B Y1472 in the SCN. Interestingly, this change is not seen prior
to EtOH withdrawal, so it appears to be induced by the cessation of EtOH consumption.
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Increases in Y1472 phosphorylation have previously been seen after chronic EtOH in the
rat striatum and in the rat hippocampus (Wang et al 2010, Wu et al 2010). Both studies
also saw no changes in total expression of NR2A and NR2B protein, consistent with our
findings (Wang et al 2010, Wu et al 2010). Our results showing increased Y1472
phosphorylation in the SCN is consistent with the glutamate hypersensitivity we observed
for the SCN circadian clock. Therefore, pharmacological inhibition of Y1472
phosphorylation during withdrawal may reduce glutamate hypersensitization in the SCN.
As with the change in NR2B:NR2A ratio, it will be important to assess whether the change
in Y1472 phosphorylation is necessary for the glutamate hypersensitivity we see during
EtOH withdrawal.
Phosphorylation of Y1472 has also been shown to enhance membrane localization
of NR2B-containing NMDA receptors. Phosphorylation of Y1472 maintains NR2B subunit
interactions with the PDZ binding domain of PSD-95 (Roche et al 2001; Pryblowski et al
2005; Zhang et al 2008). This prevents disassociation and subsequent internalization of
NMDA receptors via clathrin mediated endocytosis (Roche et al 2001; Chung et al 2004).
Although we did not see any changes in PSD-95 expression, others have likewise shown
increased Y1472 phosphorylation during withdrawal without a change in PSD-95
expression (Clapp et al 2010, Staples et al 2015). Yet there is evidence PSD-95 can play
an important role in EtOH induced plasticity, as PSD-95 KO mice exhbit increased
behavioral sensitivity to the sedative effects of EtOH (Camp et al 2011). Also, increased
clustering of PSD-95 and colocalization of NR2B containing NMDA receptors occur during
chronic EtOH (Chandler et al, 2006; Clapp et al 2010). With respect to our results,
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colocalization assays may help confirm increases in PSD-95 interactions with NR2B
during EtOH withdrawal.
Increases in mBDNF and TrkB phosphorylation occur during withdrawal
One mechanism through which Y1472 becomes phosphorylated is via TrkB
signaling. Binding mBDNF to TrkB induces autophosphorylation of the receptor, allowing
activation of downstream signals. The activation of TrkB is neuroprotective, supporting
actions that promote neuron survivability (Chao 2003). Our results showed increases in
expression of mBDNF and phosphorylation of TrkB during withdrawal. Regarding
mBDNF, a previous study demonstrated increases in total expression after 3h of
withdrawal to EtOH in the hippocampus and medial prefrontal cortex (Somkuwar et al
2016). Others have reported mixed results regarding EtOH and BDNF/TrkB interactions
(e.g., decreased BDNF binding to TrkB in the hippocampus – Kolb et al 2005; increases
in expression of BDNF, TrkB, and downstream kinases in the striatum – Logrip et al 2008).
Some have suggested these changes are region specific (Kolb et al 2003; Logrip et al
2008; but see Davis 2008), and thus the increases in mBDNF shown here may be specific
to the SCN. Regarding phosphorylation of TrkB during withdrawal, a study assessing fetal
alcohol syndrome in juvenile mice reported decreases in TrkB phosphorylation (Nona et
al 2013). Another study investigating EtOH withdrawal in the rat amygdala saw decreases
in TrkB expression, as well as decreased activation of kinases downstream of TrkB
signals (Pandey et al 2008). Therefore, increased phosphorylation of TrkB may also be
specific to the SCN. These results further elucidate the mechanism associated with
increases in Y1472 of NR2B containing NMDA receptors during EtOH withdrawal in the
SCN.
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Cellular mechanisms underlying rapid and chronic tolerance in the SCN are still unknown
Clearly there is a great deal we still do not know about the cellular changes
occurring in the SCN in response to EtOH. For example, other receptors may contribute
to the effects of EtOH in the SCN. EtOH modifies many glutamate receptors, including αamino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA) and kainate
receptors (Lack et al 2008; Lack et al 2009; Karpyak et al 2012; Corbit et al 2014; Jin et
al 2014). Beckley et al demonstrated AMPA receptor total expression in the nucleus
accumbens increases in response to a single 4-hour binge exposure to EtOH (2015).
Additionally, EtOH enhances signaling by GABA receptors, particularly the ionotrophic
GABA(A) receptors, and chronic EtOH exposure alters GABA subunit composition
(Ravindran et al 2007; Liang et al 2007; McElroy et al 2009; Gonzalez et al 2012;
Lindemeyer et al 2014). We have previously shown that at least some effects of EtOH in
the SCN involve activation of δ-subunit containing GABA(A) receptors (McElroy et al
2008). It would also be worthwhile to investigate increases in phosphorylation of Fyn,
which is down-stream of mBDNF induced TrkB activation (Yamada and Nabeshima 2004;
Carreño et al 2011). We have demonstrated previously that BDNF prevents EtOH
inhibition of glutamate-induced phase shifts in EtOH naïve SCN tissue (Lindsay et al
2014) as well as after induction of acute and rapid tolerance (Prosser and Glass 2009;
Lindsay et al 2014). It would be worth investigating the mechanisms through which BDNF,
TrkB and EtOH interact to modulate glutamate-induced phase shifts. Collectively,
investigating AMPA receptors, GABA(A) receptors, and BDNF/TrkB interactions during
tolerance and withdrawal in future experiments would likely lead to a greater
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understanding of the mechanisms associated with these EtOH induced phenomena in
the SCN.
Mechanisms upstream or downstream of NMDA receptors could also contribute to
compensatory mechanisms occurring in response to EtOH. For example, chronic EtOH
modifies the function of intracellular modulators such as Fyn, glycogen synthase kinase
3 beta (GSK3β), and STEP-61. Fyn phosphorylates the Y1472 residue and chronic EtOH
promotes Fyn activation (Trepanier et al 2012; Gibb et al 2011). Though we saw no
changes in total Fyn expression, it is possible that phosphorylation of Fyn, which activates
the kinase, may be modulated by EtOH in the SCN. Chronic EtOH increases GSK3β
activity in the cerebellum, dorsal striatum, and neuronal stem cells (Xu et al 2006;
Vangipuram and Lyman 2012, Li et al 2013). Chronic EtOH also blocks STEP-61
dephosphorylation of Y1472 of the NR2B subunit in the striatum during chronic EtOH
(Darcq et al 2014), but modulation of STEP-61 by EtOH is not seen in all brain regions
(Darcq et al 2014). Pertaining to circadian rhythms, Fyn and GSK3β either regulate the
timing of circadian periods or have a role in the photic phase shift mechanism in the SCN
(Shima et al 2000; Červená et al 2015). The role of STEP-61 has yet to be investigated
in the SCN. Because EtOH modifies the actions of extracellular glutamate and second
messengers downstream of NMDA receptors, future investigations will follow up on how
extracellular glutamate as well as activation and expression of these proteins change
during tolerance and withdrawal in the SCN.
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Conclusions
To gain a better understanding of how EtOH addiction develops and how it can be
treated, we must understand the dynamic mechanisms that occur as drinking progresses
from the short term to long term. Although many studies demonstrate specific changes in
response to a single EtOH exposure paradigm, few compare the behavioral and cellular
changes across multiple paradigms. Together with our previous studies, we have shown
that multiple forms of EtOH-induced plasticity occur in the SCN in response to distinct
EtOH exposure paradigms, and that each likely involves unique cellular mechanisms that
develop over different timeframes. Here we focused specifically on changes in NMDA
receptor subunit total expression, phosphorylation, and surface expression across these
states. We see a shift in the ratio of NR2B to NR2A subunits, and an increase in Y1472
phosphorylation that may be critical for glutamate hypersensitivity. Continuing this line of
investigation will enhance our understanding of how alcohol abuse leads to disruptions in
circadian rhythms. Moreover, the research will fill major knowledge gaps in our
understanding of the mechanisms that lead to EtOH addiction, which can lead to novel
treatments for alcohol addiction.
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Figure 3.1 Chronic tolerance to ethanol (EtOH) inhibition of glutamate-induced phase
delays. (A-D) Shown are the 2-hour mean ± SEM of suprachiasmatic nucleus neuronal
activity obtained in individual experiments. (A) Extracellular electrophysiological
recordings in SCN tissue from an EtOH naïve mouse with no drug treatment peak at
Zeitgeber time (ZT) 6. (B) A 10 min bath application of 1mM glutamate (glu) at ZT16 to
SCN tissue from an EtOH naïve mouse induces a ~2.5 hour phase delay. (C) Coapplication of 20mM EtOH with 1mM glutamate blocks glutamate induced phase delays
in SCN tissue from an EtOH naïve mouse, indicating that the glu-induced phase delay is
inhibited. (D) Co-application of 20mM EtOH and 1mM glutamate does not inhibit
glutamate induced phase shifts in SCN slices from a mouse that had undergone the
chronic protocol for 10 days. Horizontal bars: time of lights-off in the animal colony;
vertical bars: time of drug treatment(s); dotted line: mean time of peak in control
experiments. (E) Shown are the mean ± SEM phase shifts from experiments involving
glutamate and EtOH applied to brain slices of mice after 10 days of the chronic drinking
protocol. Bath application of 1mM glutamate induces significant phase delays. Coapplication of 20mM EtOH does not block phase shifts. Phase shifts still occur with
150mM EtOH, but are inhibited by 200 mM EtOH n=3-7. (F) Plotted are the mean peak
(± SEM) change in phase shifts induced in brain slices of mice drinking 15% EtOH for
differing amounts of time in number of days – then treated with 1mMglutamate + 20mM
EtOH determines the number of consecutive days of drinking necessary before tolerance
occurs. 8 days of drinking is needed for 20mM EtOH to no longer inhibit glu-induced
phase shifts. One-way ANOVA indicated a significant effect of treatment, *Post hoc
(Holm-Sidak) test indicates p < 0.05 versus control experiments. ** p<0.01
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Figure 3.2 Sensitization to glutamate in the SCN after EtOH withdrawal. (A) Plotted are
the mean peak (± SEM) delays after 0uM, 1uM, and 10uM glutamate after no drinking
(white bars, n=3), 21 days of drinking (gray bars, n=3), and 21 days of drinking with two
days withdrawal (orange bars, n=3). **Post hoc (Holm-Sidak) test indicates p < 0.01
versus the 0 uM glutamate EtOH naïve condition. (B) Plotted are the mean peak (± SEM)
firing rates induced by 1uM glutamate treatment in mice that have undergone 2 days of
chronic withdrawal from EtOH after varying numbers of days of chronic drinking. **Post
hoc (Holm-Sidak) test indicates p < 0.01 versus the 10 days of drinking condition. (C)
Plotted are the mean peak (± SEM) firing rates induced by 1uM glutamate treatment in
mice that have undergone a varying number of days of chronic withdrawal from EtOH
after 21 days of chronic drinking. **Post hoc (Holm-Sidak) test indicates p < 0.01 versus
the 10 days of drinking condition.
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Table 3.1 Summary of Western blot results comparing tissue from EtOH naïve mice with
mice exposed to the different EtOH drinking paradigms. Significant changes compared to
control conditions were noted for the NR2B/NR2A ratio (2B/2A), phosphorylation of the
NR2B subunit at the Y1472 residue (Y1472), total expression of mBDNF (mBDNF), and
phosphorylation of TrkB at Y706 residue (pTrkB). All experiments were performed relative
to actin and normalized to control. <0.05 represent p-values for results with significant
changes compared to control conditions and ‘x’s represent no significant changes.
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Figure 3.3 Total expression of NR2B, NR2A, and NR2B:NR2A ratio after rapid, chronic
10 days, chronic 21 days, and withdrawal procedures. (A) Above, plotted are the mean
band densities (± SEM) for total expression of NR2A normalized to control tissue and
relative to actin (n=7 for all conditions). Below are representative images for NR2A band
densities across all treatments, respectively. (B) Above, plotted are the mean band
densities (± SEM) for total expression of NR2B normalized to control tissue relative to
actin (21D n=7; other variables n=11). Below are representative images for NR2B band
densities across all treatments, respectively. (C) Plotted are the mean ratios of band
densities for NR2B to NR2A total expression normalized to control tissue and relative to
actin (n=7 for all conditions). Tissue from control untreated mice (ctl), mice drinking
overnight (RT), mice chronic drinking for 10 days (CT), mice chronic drinking for 21 days
and mice chronic drinking for 21 days with 2 days withdrawal (WD) treatments to SCN
slices. *Post hoc (Holm-Sidak) test indicates p<0.05 versus control experiments.

133

C

1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0

al
ol
ht
ay
ay
n tr r n i g 10 d 21 d d r aw
o
e
C
th
Ov
Wi

NR2B protein expression level
(relative to actin normal to control)

NR2A protein expression level
(relative to actin normal to control)

B

NR2A

NR2B:NR2A

5

*

4

*

3
2
1
0
n
Co

NR2B
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0

n
Co

180 kDa
42 kDa

170 kDa
42 kDa
NR2B:NR2A protein expression ratio
(relative to actin normal to control)

A

l
l
t
y
y
tr o n i g h 0 d a 1 d a r aw a
r
2
1
e
th d
Ov
Wi

134

l
l
t
s
s
tr o n i g h d ay d ay r aw a
r
1
0
d
e
2
1
th
Ov
Wi

Figure 3.4 Total expression of NR2A and PSD-95 after rapid, chronic 10 days, chronic
21 days, and withdrawal drinking procedures. (A) Plotted are mean band densities (±
SEM) for Y1472 phosphorylation of the NR2B subunit of the NMDA receptor normalized
to control tissue and relative to actin across different conditions (n=3 for 21D, n=8 for
other conditions). Below are representative images for Y1472 band densities across all
treatments, respectively. *Post hoc (Holm-Sidak) test indicates p<0.05 versus control
experiments. (B) Plotted are the mean band densities (± SEM) for the ratio of Y1472
phosphorylation to NR2B total expression normalized to control tissue and relative to
actin (n=6 for all conditions). (C) Above, plotted are mean band densities (± SEM) for
mBDNF total protein expression normalized to control tissue and relative to actin across
different conditions (n=6 for all conditions). Below are representative images for mBDNF
band densities across all treatments, respectively *Post hoc (Holm-Sidak) test indicates
p<0.05 versus control experiments. (D) Above, plotted are mean band densities (± SEM)
for tyr 706 phosphorylation of the TrkB receptor normalized to control tissue and relative
to actin across different conditions (n=3 for 21D, n=8 for other conditions). Below are
representative images for tyr 706 band densities across all treatments, respectively.
**Post hoc (Holm-Sidak) test indicates p<0.05 versus all conditions.
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Chapter 4
General Conclusions
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Summary of conclusions
The goals of this research project were to investigate EtOH induced rapid
tolerance, chronic tolerance, and withdrawal induced sensitization in the SCN, and
compare the cellular changes induced under each condition. Many research groups
investigating EtOH-induced responses in the brain utilize only one model for EtOH
exposure. Although these previous studies have shown that EtOH alters cellular
processes like glutamate signaling, they provide little insight into the progression of
changes that develop across different durations of EtOH exposure. Consistent with these
studies, previous results in our lab demonstrate that EtOH inhibits glutamate signaling in
the SCN, as assessed by its ability to inhibit glutamate-induced phase-shifts of the SCN
circadian clock in vitro, as well as inhibiting photic phase resetting in vivo (Prosser 2003).
We also showed the circadian clock develops acute tolerance to EtOH inhibition of
glutamate phase shifts in vitro (Prosser and Glass 2009). Based on these results, we
hypothesized that rapid tolerance, chronic tolerance, and withdrawal induced
sensitization also occur in the SCN. Furthermore, we believed that the circadian clock
would be an excellent model system for investigating the cellular changes associated with
rapid tolerance, chronic tolerance and withdrawal induced sensitization.
Given that we observed acute EtOH tolerance in the SCN in vitro (Prosser and
Glass 2009), it seemed surprising that chronic applications of EtOH continue to inhibit
photic phase shifts in vivo (Rosenwasser et al 2005; Seggio et al 2007; Seggio et al 2009;
Ruby et al 2009; Brager et al 2010; Brager et al 2011). From this, we wondered whether
these differences were due to procedural differences in our in vitro vs in vivo
assessments, or if they were due to the presence or lack of extra-SCN influences under
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the two conditions. With this in mind, we set out to determine whether rapid tolerance,
chronic tolerance, and withdrawal induced sensitization occur in the SCN, and if they do,
to determine whether they involve changes in glutamate receptors. We hypothesized that
EtOH-induced plasticity in the SCN is associated with changes in NR2B containing NMDA
receptors in the SCN, and that the extent and manner of these changes differ across
multiple forms of EtOH plasticity.
In the experiments presented in chapter two, we demonstrated that rapid tolerance
to EtOH develops within 24 hours of initial EtOH access. This effect is seen with respect
to both phase delays (ZT16) and phase advances (ZT23), and is exhibited both in vivo
and in vitro. The dose of EtOH necessary to inhibit glutamate induced phase shifts during
rapid tolerance is ten-fold the normal amount. Rapid tolerance lasts between 48 and 72
hours for the phase delays, and between 72 and 96 hours for the phase advances. In
chapter three, we demonstrated that chronic tolerance can be seen using our in vitro
phase-resetting paradigm, and that it develops after a minimum of 8 days of drinking. The
dose of EtOH necessary to inhibit glutamate induced phase shifts during chronic
tolerance is 10-fold the normal amount, consistent with what we observed with rapid
tolerance. We also demonstrated that an increased sensitivity to glutamate-induced
phase shifts is seen in the SCN in vitro when assessed 2 days after EtOH withdrawal
following at least 14 days of EtOH consumption. This withdrawal induced glutamate
hypersensitivity is still apparent at 4 days but not at 6 days after abstinence.
Having clearly defined the timing and dosing parameters associated with these
forms of EtOH plasticity, we proceeded to investigate the underlying cellular mechanisms.
We determined that distinct changes in NMDA receptor subunits accompany the different
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forms of plasticity in the SCN: an increase in the ratio of NR2B:NR2A subunits is seen
after 21 days of drinking and during EtOH withdrawal, but not after a single night of forced
EtOH consumption or even after ten days of drinking using the drinking in the dark
paradigm. Increased phosphorylation at the NR2B tyrosine1472 (Y1472) residue is seen
after EtOH withdrawal, but not after 21 days of drinking. Upstream of Y1472
phosphorylation, we determined increases in mBDNF total protein expression and TrkB
phosphorylation occur during withdrawal, but not in any other conditions, matching results
showing Y1472 phosphorylation. Surprisingly, in none of the conditions did we see
changes in NR1 total protein expression, NR2B S1480 phosphorylation, nor did we see
changes in PSD-95 and total protein expression of Fyn. Taken together, these results
demonstrate that distinct physiological and cellular responses accompany each form of
EtOH tolerance and EtOH withdrawal, and suggest that EtOH-induced plasticity in the
SCN may differ from that seen in other brain regions.

Rapid tolerance to EtOH develops in the SCN
Rapid tolerance occurs after acute tolerance and before chronic tolerance. Some
studies have suggested that the development of rapid tolerance may be a good predictor
of subsequent chronic tolerance development (Khanna et al 1991a; Wu et al 2001;
Radcliffe et al 2006). Like the other forms of ETOH tolerance, a decrease in EtOHinduced hypnotic, motor, and hypothermic effects is seen during rapid tolerance
(Gilliam 1989; Silveri and Spear 1999). What distinguishes rapid tolerance from other
forms of EtOH tolerance besides its timing could be the underlying cellular substrates.
Pharmacologically, blocking NMDA receptors with the selective antagonist, MK-801,
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blocks behavioral manifestations of rapid tolerance (Khanna et al 1991b; 1993). A
separate study demonstrated that NR2A knock-outs but not NR2B knock-outs reduce but
do not eliminate the decreased sleep/sedative effects of EtOH seen during rapid
tolerance, supporting the notion that NR2A subunits play a role in rapid tolerance to EtOH
induced sedation (Palachick et al 2008). However, there is no information on changes in
protein expression and/or phosphorylation of NMDA receptor subunits during rapid
tolerance. Thus we attempted to identify physiological characteristics and changes in
NMDA receptor subunits and other proteins that could regulate NMDA receptor function
during rapid tolerance.
The findings in chapter two demonstrate that rapid tolerance is exhibited by the
SCN both in vivo and in vitro 24 hours after access to EtOH. These results are consistent
with other studies investigating the timing of rapid tolerance development with respect to
EtOH-induced hypothermia, ataxia, and sleep promotion in various rodent models
(Khanna et al 1991a; Radcliffe et al 2006; Sharma et al 2014). In our study, the duration
of rapid tolerance differed between glutamate-induced phase delays and phase
advances, lasting 48-72 hours and 72-96 hours, respectively. To our knowledge, this is
the first time the duration of rapid tolerance has been determined. Though we did not
address why the duration of tolerance differs between phase delays and phase advances,
these phase-shifting processes have distinct cellular mechanisms that could be
differentially modified by EtOH tolerance (Gillette and Mitchell 2002).
As mentioned, little is known about modulation of NMDA receptors and NMDA
receptor related signals during rapid tolerance. We hypothesized that proteins that
regulate NMDA receptor function may be modulated during rapid tolerance. A major
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component of NMDA receptor regulation is BDNF-induced TrkB activation (Chao 2003;
Mizuno et al 2003). TrkB phosphorylates and activates Fyn kinase (Yamada and
Nabeshima 2004; Carreño et al 2011), which leads to increased activation of NMDA
receptors via Fyn-induced phosphorylation of the NR2B subunits (Nakazawa et al 2001;
Goebel et al 2005). In the SCN, BDNF signaling is needed for glutamate/photic phase
shifting (Liang et al 2000; Kim et al 2006; Mou et al 2009; Cooper et al 2017). We have
demonstrated that application of exogenous BDNF prevents acute EtOH inhibition of
phase shifts (Prosser et al 2008). We subsequently demonstrated that exogenous BDNF
prevents EtOH inhibition of glutamatergic phase shifts during rapid tolerance. Despite
these data pointing to the importance of BDNF/TrkB/NMDA signaling in glutamateinduced phase shifts, we found no rapid tolerance-associated changes with respect to
NMDA receptor NR1, NR2A, or NR2B subunit expression, NR2B phosphorylation at
Y1472, S1303, or S1480, or TrkB, BDNF, PSD-95, and Fyn kinase total expression.
These results raise a number of possibilities: 1) Rapid tolerance may not involve
changes in NMDA receptors. This would mean that the cellular changes underlying rapid
tolerance are different from those associated with both acute and chronic tolerance (Läck
et al 2005; Miyakawa et al 1997; Nagy 2008; Roberto et al 2006; Trepanier et al 2012).
Given the distinct time courses of these different forms of tolerance, this would not be
especially surprising. 2) Rapid tolerance may involve NMDA receptor-associated
compensatory responses not investigated here. For example, chronic EtOH induces
increases in STEP-33 and p38 MAPK, without altering Src, Lyn, and Fyn kinases (Wu
et al 2010). Though we did not see changes in phosphorylation of NR2B Y1472, it is
possible STEP-33 and p38 MAPK alter phosphorylation of other residues on NR2B or
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different subunits of the NMDA receptor during rapid tolerance. On another note, acute
EtOH typically alters phosphorylation of NR1 subunit residues (Xu et al 2010; Roh et al
2011). These changes may still be present during rapid tolerance. 3) Compensatory
responses during rapid tolerance may involve other receptors like GABA(A)δ receptors.
In support of this, we previously demonstrated the acute actions of EtOH in the SCN
involve GABA(A)δ receptors (McElroy et al 2009). Future investigations of rapid tolerance
in the SCN could focus on any of these cellular mechanisms.

Chronic tolerance to EtOH develops in the SCN
Chronic tolerance takes longer to develop than acute and rapid tolerance. Reports
have shown chronic tolerance in rodents with respect to EtOH metabolism and EtOHinduced ataxia after 10 days to 2 weeks of EtOH exposure (Broadwater et al 2011; Matson
et al 2014). Manifestations of chronic tolerance are also seen after longer durations of
continued use, including tolerance to the hypnotic effects of EtOH (e.g., 20 days in
Matthews et al 2008; 60-90 days in Darbra et al 2002; 120+ days in Cagetti et al 2003).
At the cellular level, long-term EtOH exposure has been shown to induce changes in both
NMDA and GABA(A) receptor activity. Studies demonstrate that NMDA receptorassociated Ca2+ currents increase while GABA receptor-associated Cl- currents decrease
during chronic tolerance, which in both cases can lead to a hyperexcitable state (Iorio et
al 1992; Buck et al 1991). Although changes in NMDA and GABA receptor signaling are
seen during both acute and rapid tolerance (Allan and Harris 1987; Buck et al 1991;
Grover et al 1994; Silveri and Spear 1999; Silveri and Spear 2004), the changes in NMDAand GABA-receptor ion currents appear to occur exclusively during chronic tolerance or
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at least have yet to be identified in acute and rapid tolerance. These data support the
conclusion that the mechanisms underlying acute and rapid EtOH tolerance vs. chronic
EtOH tolerance are distinct.
It is possible that the shorter duration of EtOH exposure associated with acute and
rapid tolerance only allows for changes in the activity of second messengers, while
chronic EtOH exposure allows for transcriptional/translational changes (Kalant 1996;
Pietrzykowski and Treistman 2008). Thus, total expression of receptor subunits and
phosphorylation of key residues of NMDA receptor and GABA receptor subunits are seen
during chronic EtOH tolerance while they have not been reported during acute and rapid
tolerance. Specifically, increases in NR2B expression and phosphorylation (Suvarna et
al 2005; Wang et al 2011), increases in surface localization of GABA α4 subunits (Liang
et al 2007), and increases in GABA β2 and γ2 subunit phosphorylation have been
reported during chronic tolerance (Ravindran & Ticku 2006). Importantly however, none
of these prior studies compared multiple forms of EtOH-induced plasticity within a single
study, which makes drawing clear distinctions between their cellular substrates more
difficult.
Our electrophysiological results show that the SCN develops chronic tolerance to
EtOH as seen by a decrease in EtOH inhibition of glutamate-induced phase shifts in vitro.
This is similar to our in vitro results regarding acute and rapid tolerance in the SCN
(Prosser and Glass 2009). However, this differs from in vivo studies showing that chronic
EtOH continues to inhibit photic phase shifts (Ruby et al 2009; Brager et al 2010). In
comparing these in vivo studies with our in vitro experiments there are a few
methodological differences. In the previous studies, the mice had higher daily EtOH
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consumptions (20g/kg/day vs. 2.84g/kg/day), they were drinking EtOH for a longer overall
period (14 days vs. our 10 days), drinking was not restricted to 4 h each day, and
tolerance was not assessed using different intensities of the phase-shifting stimulus
(light). A separate study demonstrated that chronic forced EtOH consumption, where
more EtOH is consumed, inhibits photic phase delays in vivo, while chronic voluntary
consumption, where less EtOH is consumed, does not inhibit phase shifts (Seggio et al
2009). With this in mind, a study in our lab suggests that EtOH also enhances
serotonergic phase shifts, and that this occurs at least in part through inhibiting
glutamatergic signaling (Prosser et al 2008). Interestingly, serotonin receptors have been
shown to regulate glutamate release into the SCN (Pickard et al 1996; Smith et al 2001;
Sprouse et al 2004). Therefore, the effects of EtOH in the SCN may include increasing
serotonergic signaling and decreasing glutamate release. This is supported by reports
showing increased serotonin 1a receptor sensitivity during chronic EtOH (Esteban et al
2001). Thus, in vivo experiments would show results consistent with glutamatergic phase
shift inhibition during chronic EtOH at higher EtOH concentrations, but not at lower EtOH
concentrations as assessed in Seggio et al 2009. It will be important to further explore the
critical variables determining whether chronic tolerance is seen in the SCN in vivo.
Importantly, identifying factor(s) such as serotonin that potentially protect the circadian
clock from exhibiting chronic tolerance in vivo could provide insight into treatments for
those dependent on alcohol.
As with rapid tolerance, we characterized the change in sensitivity and timing
parameters of both chronic tolerance and withdrawal induced glutamate hypersensitivity.
We determined that chronic tolerance is characterized by a 10 fold right-ward shift in the
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dose response curve for EtOH inhibition of glutamate induced phase shifts, similar to the
changes in sensitivity seen with rapid tolerance. We also determined that, using our
assessment protocol, it takes 8 days of drinking to develop chronic tolerance. To our
knowledge, this is the first experiment to carefully assess how many days of consecutive
drinking are necessary for chronic tolerance to develop. Previous studies have sometimes
used 7-14 days of EtOH consumption to investigate chronic tolerance (Broadwater et al
2011; Matson et al 2014). Although this duration of EtOH exposure is generally consistent
with our results, it might be worthwhile for researchers to adopt a paradigm that includes
at least 8 days of EtOH consumption when investigating chronic tolerance.
There are still many unanswered questions regarding the cellular changes
associated with chronic tolerance. As with rapid tolerance, it is possible that chronic
tolerance does not require changes in NMDA receptor expression. Although other studies
have reported changes in NMDA receptors during chronic tolerance (Nagy 2008; Roberto
et al 2006; Wu et al 2010), most involved much longer periods of EtOH exposure. So it is
not clear whether the changes induced in the SCN by chronic EtOH exposure differ from
those of other regions or whether the difference is due to different durations of EtOH
exposure. A second possibility is that chronic tolerance in the SCN involves changes in
other receptors. Many reports have demonstrated modulation of GABA(A) receptors and
AMPA receptors during chronic EtOH tolerance in the amygdala and cortex (Liang et al
2007; Ravindran et al 2007; Liang et al 2009; Lindemeyer et al 2014; Nimitvilai et al 2016;
see below). Chronic tolerance may also involve processes upstream and/or downstream
of NMDA receptors that were not investigated here. We saw no changes in total
expression of Fyn, however other reports have demonstrated that phosphorylation of Fyn

146

is increased during chronic EtOH (Gibb et al 2011). Seeing that our results demonstrated
increases in mBDNF and TrkB phosphorylation during withdrawal, increased
phosphorylation of Fyn via TrkB signals during withdrawal is likely. Finally, we did not
assess glutamate levels in the SCN, but others have reported increases in extracellular
glutamate associated with chronic EtOH exposure (Rossetti and Carboni, 1995; Ding et
al 2012; Ding et al 2013; Griffin et al 2013), which could affect signaling in the SCN
through homeostatic synaptic changes. Investigating these possibilities should help
distinguish the cellular changes associated with chronic tolerance from those of other
forms of tolerance.

Withdrawal from EtOH increases circadian clock sensitivity to glutamate-induced
phase resetting.
The behavioral effects of withdrawal from EtOH are distinct from those associated
with EtOH tolerance. For example, withdrawal can lead to insomnia, psychomotor
agitation, hallucination, and seizures (Schuckit 2014), while tolerance is primarily
characterized by a loss or reduction in EtOH-induced behaviors, such as decreased EtOH
induced sleep, ataxia, and hypothermia (Khanna et al 1991a; Radcliffe et al 2006; Sharma
et al 2014). Nevertheless, the cellular changes seen with EtOH withdrawal and EtOH
tolerance overlap. Some studies have demonstrated that withdrawal is associated with
increases in extracellular glutamate (Ding et al 2013; Griffin et al 2013), a response also
seen during chronic EtOH (Roberto et al 2004; Christian et al 2013). Conversely, studies
investigating the hippocampus and bed nucleus of the stria terminalis (BNST) have shown
that synaptic localization of NR2B subunits decreases during EtOH withdrawal (Clapp et
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al 2010; Wills et al 2012), which contrasts with increased synaptic localization of NR2B
subunits during chronic EtOH (Clapp et al 2010). With this in mind, we assessed the same
glutamate signaling-associated proteins during EtOH withdrawal as we assessed after
rapid and chronic tolerance.
We determined that glutamate hypersensitivity, characterized by a 10 fold left-ward
shift in the dose response curve for glutamate induced phase delays, is seen after at least
14 days of EtOH consumption followed by 2-6 days of EtOH withdrawal. Others have
shown that withdrawal induced convulsions can develop after as few as four days of EtOH
vapor inhalation in mice (Olive and Becker 2008), although this paradigm involves a more
intensive exposure to EtOH and thus potentially much higher blood ethanol concentration
levels than the drinking in the dark paradigm we used. Others have shown EtOH
withdrawal associated seizures after EtOH drinking for 2 weeks (Roberto et al 2004) or
1-2 weeks (Wang et al 2010) in rodent models, which is more consistent with our results.
Some studies have reported EtOH withdrawal induced convulsions lasting as little as 410 hours after EtOH withdrawal (Farook et al 2008; Olive and Becker 2008) while other
effects, such as locomotor sensitization, last upwards of 11 days after EtOH withdrawal
(Abrahao et al 2013). Importantly, our data showing that chronic drinking prior to
withdrawal does not lead to glutamate hypersensitization is consistent with other studies.
This suggests that withdrawal induced plasticity requires a period of abstinence to
develop.
The increase in NR2B:NR2A expression we observed after 21 days of drinking is
still seen during EtOH withdrawal. This increase could be one component of the
mechanism underlying withdrawal induced glutamate hypersensitivity. Only after
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withdrawal did we also see an increase in phosphorylation of the NR2B Y1472 residue.
Increases in the phosphorylation of NR2B Y1472 potentiate NMDA receptor currents and
lead to synaptic membrane recruitment of these receptors (Nakazawa et al 2001; Goebel
et al 2005). Once the NMDA receptors are localized to the membrane, phosphorylation
of Y1472 also maintains their localization within the synapse (Goebel et al 2005) via
interactions with the scaffolding protein, PSD-95 (Roche et al 2001; Prybylowski et al
2005; Zhang et al 2008). These changes are associated with hyperexcitable states in
neurons and have been demonstrated in other brain regions during EtOH withdrawal. For
example, increases in NR2B Y1472 in the hippocampus and the dorsomedial striatum
have been reported during EtOH withdrawal (Pawlak et al 2005; Wang et al 2010). Thus,
the glutamate hypersensitivity seen during withdrawal could be due to a combination of
increased NR2B:NR2A expression and increased NR2B Y1472 phosphorylation. These
changes would be expected to increase NMDA receptor excitatory postsynaptic potentials
as seen in the amygdala, dorsomedial striatum and hippocampus (Roberto et al 2004;
Wang et al 2010; Wu et al 2010). An important test of this scenario would be to investigate
synaptic localization of NR2B containing NMDA receptors during EtOH withdrawal.
Although we did follow up using cell surface biotinylation, we did not see a significant
increase with respect to NR2B subunit surface expression (n=6, data not shown).
However, these results did show trending increases in NR2B surface expression during
withdrawal. Therefore, we cannot exclude the possibility that chronic EtOH and
withdrawal modulate surface expression of NMDA receptor subunits.
One mechanism through which Y1472 phosphorylation occurs is via TrkB receptor
activation. proBDNF becomes cleaved to generate its mature form by many proteins,
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including plasmin after its activation by tissue plasminogen activator (tPA) (Pang et al
2004). Mature BDNF is then capable of binding TrkB, inducing TrkB dimerization, and
allowing autophosphorylation. We showed an increase in mBDNF total protein expression
during withdrawal, which is consistent with tPA dependent increases in Y1472 during
EtOH withdrawal (Pawlak et al 2005). Furthermore, an increase in phosphorylated TrkB
at Tyr 706 occurred during withdrawal. Other studies have demonstrated similar results.
For instance, increases in BDNF protein expression have been reported in the rat
hippocampus and medial prefrontal cortex after a 3h withdrawal from chronic intermittent
ethanol ([CIE], Somkuwar et al 2016). Another investigation in the mouse dorsal lateral
striatum showed that p75, a neurotrophin factor receptor that pro BDNF binds and
opposes TrkB signals, increases after cessation of 21 days of 2 bottle access CIE for 24
h, suggesting EtOH withdrawal induces neuroadaptive responses (Darcq et al 2016). Yet
we showed increases in TrkB phosphorylation, suggesting withdrawal induced
sensitization to glutamate in the SCN is acting through TrkB signals. Others have shown
that acute ethanol blocks TrkB phosphorylation mediated NR2B containing NMDA
receptor activation (Kolb et al 2005). Thus the nature of this response may be
compensatory, as the removal of EtOH due to withdrawal may leave previous inhibition
of TrkB phosphorylation by EtOH unchecked (see Figure 4.1).
We have summarized our data demonstrating changes in the glutamatergic phase
shift mechanism across control conditions, overnight/10 day chronic drinking, 21 day
chronic drinking, and 21 days of drinking followed by withdrawal (Figure 4.1). The
changes across each condition are represented in a timeline to gain perspective on when
each EtOH induced plasticity develops.
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Future directions
Ethanol-induced plasticity
We demonstrated that rapid tolerance, chronic tolerance, and withdrawal
hypersensitivity all occur in the SCN. However, we were unsuccessful in fully delineating
the cellular mechanisms contributing to these responses. We believe it is likely that
additional receptors participate in these phenomena.

Some likely candidates are

discussed below.
GABA(A) receptors
GABA(A) receptors reduce neuronal activation throughout the brain, and generally
act to counteract glutamate-induced excitation. In the SCN pharmacological inhibition of
GABA(A) receptors can enhance photic/glutamate phase shifts, while GABA(A) receptor
activation can inhibit these phase shifts, confirming GABA(A) receptor regulation of photic
phase shifts (Ralph and Menaker 1989; Gillespie et al. 1997; Herzog et al 2017). GABA(A)
receptors contain 5 total subunits, with the most common isoforms including 2 α subunits,
2 β subunits, and either a γ or δ subunit (Olsen and Sieghart 2009). The α and β subunits
are important for regulating ion channel conductance properties, while the γ and δ
subunits regulate the localization of GABA receptors in and out of the synaptic active
zone, respectively. The characteristics of γ and δ containing-GABA(A) receptors also
differ in that they generate phasic and tonic currents, respectively (Farrant and Nusser
2005).
Post-translational modifications such as phosphorylation contribute to the
regulation of GABA(A) receptors. Phosphorylation of key residues of different subunits of
GABA(A) receptors modify localization to the membrane and receptor kinetics (Abramian
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et al 2010; Bright and Smart 2013; Bohnsack et al 2016). Therefore, post-translational
modifications of GABA(A) receptors can lead to substantial changes in the regulation of
neuronal activity.
As with glutamate signaling, EtOH modifies GABA signaling in a manner that
differs based on the duration of EtOH exposure. Acute EtOH enhances GABA receptor
ion conductance (Wei et al 2004; Olsen et al 2007), while chronic EtOH reduces GABA
receptor activation and expression, and alters phosphorylation of GABA(A) subunits
(Kumar et al 2003; Liang et al 2007; Bright and Smart 2013; Abramian et al 2010; Ron
and Messing 2013). EtOH can also modify the function of kinases and phosphatases that
regulate GABA(A) receptor mobilization to and from the membrane (Brandon et al 2000;
Brandon et al 2003; Carlson et al 2013; Carlson et al 2014; Choi et al 2008; Kumar et al
2010). Changes in GABA(A) receptors have been shown during acute, rapid, and chronic
tolerance, including changes in GABA(A) receptor currents, subunit expression, and
phosphorylation (Allan and Harris 1987; Buck et al 1991; Barbosa and Morato 2001;
Ravindran et al 2007, Liang et al 2007, Gonzalez et al 2012, Lindemeyer et al 2014). One
target of EtOH induced effects we are especially interested in exploring is δ subunit
containing GABA(A) receptors. Previously we showed that application of R015-4513, a
GABA(A) δ subunit selective antagonist, prevents EtOH inhibition of glutamate induced
phase delays, suggesting that EtOH acts in part on GABA(A) receptors to inhibit photic
phase shifts (McElroy et al 2009). Following up on these experiments by investigating
potential changes in the expression levels and localization of GABA(A) δ subunits during
EtOH tolerance and withdrawal may reveal more on these tolerance mechanisms.
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AMPA receptors
Glutamatergic AMPA receptors contribute substantially to regulating neuronal
excitation. Each AMPA receptor is composed of 4 subunits, forming a heterotetramer that
assembles in a ‘dimer of dimers’ configuration (Mayer 2005). The different subunit types
include GluR1-R4 and always assemble in pairs. Phosphorylation of these receptors
modifies membrane localization, ion channel conductance, and the probability the
channel is open (Derkach et al 1999; Banke et al 2000; Hayashi et al 2000; Boehm et al
2006). Some studies have demonstrated that in vivo and in vitro applications of AMPA
phase shift the clock, suggesting an important role for AMPA receptors in photic phase
shift mechanisms (Takeuchi et al 1991; Mizoro et al 2010).
Many reports have shown that EtOH modulates AMPA receptors. Though not as
sensitive to acute EtOH as NMDA receptors (Möykkynen and Korpi 2012), acute EtOH
inhibits AMPA receptor currents in adolescent rodents (Zhu et al 2007; Puglia and
Valenzuela 2010). In contrast, chronic EtOH enhances the amplitude of AMPA receptor
small excitatory postsynaptic currents in the basolateral amygdala of rats (Läck et al
2007). Chronic EtOH and EtOH withdrawal also alter AMPA subunit expression, subunit
trafficking, and phosphorylation in the rodent amygdala and cortex (Christian et al 2012;
Agoglia et al 2015; Nimitvilai et al 2016; Salling et al 2016). Regarding EtOH tolerance,
AMPA receptor antagonists block formation of rapid tolerance associated with motor
coordination behaviors in mice (Rial et al 2009). Also, chronic intermittent EtOH
suppresses acute EtOH inhibition of AMPA receptor induced potentials in the orbitofrontal
cortex of mice, suggesting AMPA receptors contribute to tolerance (Nimitvilai et al 2016).
Because chronic EtOH and EtOH withdrawal modulate phosphorylation, trafficking, and
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conductance of the AMPA receptor, AMPA receptors would be worth investigating using
our multiple model approach.
Serotonin Receptors
Serotonin (5-HT) receptors mediate a variety of neurological processes including
learning and memory, mood, and locomotion. In the SCN, 5-HT receptors mediate nonphotic phase shifts (Medanic and Gillette 1992; Prosser 2003; Sprouse et al 2004). 5-HT
receptors can also modify SCN responses to light, particularly the 5-HT1A, 5-HT1B, 5HT3, 5-HT5A, and 5-HT7 receptor subtypes. These receptors modulate SCN neuron
activity via inputs from other regions and within the SCN. For example, applying the
selective 5-HT1B receptor agonist TFMPP to the SCN inhibits light induced phase shifts
by reducing presynaptic glutamate release (Pickard et al 1997), while 5-HT1B KO mice
have reduced responses to photic phase shifts (Sollars et al 2006). Activation of 5HT3
receptors on retinohypothalamic tract terminals induces photic phase shifts by increasing
the release of glutamate on to SCN neurons (Graff et al 2006). In contrast, activation of
5-HT7 receptors in SCN neurons reduces amplitude of excitatory post-synaptic currents,
and thus inhibits postsynaptic glutamate responses in the SCN (Smith et al 2001; Sprouse
et al 2004).
EtOH also affects serotonin receptor function, particularly 5-HT1A, 5-HT1B, and 5HT3 receptor subtypes, and the effects of EtOH differ depending on exposure duration.
Behaviorally, mice with 5HT1A and 5HT1B receptor knockouts have increases in EtOH
consumption and EtOH intoxication (Lovinger 1997). Acute EtOH also enhances 5-HT3
receptor activation (Vengeliene et al 2008). Conversely, chronic EtOH increases
expression of the 5-HT1A (Burnett et al 2014) and 5-HT1B receptors in the macaque
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hippocampus (Pandey et al 1996). Unfortunately, little is known about the effects of
chronic EtOH on 5-HT3 receptors, although recent evidence shows that alcoholic patients
have increased 5-HT3 receptor A subunit mRNA expression compared to non-alcoholics
(Xu et al 2016). It appears that no research has been done on the effects of chronic EtOH
and EtOH withdrawal on 5-HT3 receptors. Because acute and chronic EtOH alter
serotonin receptor subtypes critical for regulating phase resetting in the SCN, it would be
worthwhile to investigate changes in these receptors during EtOH tolerance and
withdrawal.
The effects of EtOH metabolites in the SCN
Acetaldehyde, the first metabolite of EtOH metabolized from cytochrome p450 in
the brain, causes many problems associated with EtOH abuse. For example,
acetaldehyde accumulation is neurotoxic (Takeuchi et al 2003), can promote spreading
of tumors by inhibiting DNA repair (Seitz and Meuller 2015), and induces addictive like
behavior in animal models by activating dopamine neuron firing in the mesolimbic system
(Foddai et al 2004; Deehan et al 2013; Brancato et al 2014). The effects of acetaldehyde
on dopamine neurons in the ventral tegmental area are thought to occur by modulation
of A-type K+ currents and shortening the interval between hyperpolarization-activated
inward rectifying currents (Melis et al 2007). A-type K+ channels are also found in the
SCN, where they regulate SCN neuron excitability (Itri et al 2010; Granados-Fuentes et
al 2012). Thus, it is possible that at least some of our effects are caused by acetaldehyde
rather than EtOH. To test this, we could co-apply catalase inhibitors with glutamate and
EtOH to the SCN in vitro during the early or late night. If the glutamate-induced phase
shifts are not blocked, this would suggest glutamate phase shift inhibition involves
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acetaldehyde. Follow-up experiments could also investigate whether tolerance to
inhibition of phase shifts and withdrawal induced sensitization to glutamate is induced by
drinking an acetaldehyde/water solution at various concentrations, depending on the type
of tolerance or sensitization under question.
Astroglia and glutamate release
A recent paper by Brancaccio et al., (2017) showed that the timing of extracellular
glutamate release is pivotal for maintaining circadian timekeeping. During the night, the
level of extracellular glutamate peaks in the SCN, a process controlled by astrocytes.
Other players in this mechanism include excitatory amino acid transporters (EAAT)
responsible for glutamate reuptake, and NR2C containing NMDA receptors that may be
located on GABAergic presynaptic terminals, which would allow the extracellular
glutamate to regulate GABA release (Brancaccio et al 2017). As in other brain regions
(Gass and Olive, 2008; Brager et al 2012; Ding et al 2012; Ding et al 2013; Griffin et al
2013) chronic EtOH could modulate extracellular glutamate levels in in the SCN.
Experiments assessing potential changes in total expression of EAAT and NR2C subunits
during EtOH tolerance and withdrawal, as well as extracellular glutamate levels, could
provide evidence for this possibility.

Conclusions
We have demonstrated the utility of the SCN as a model system for investigating
EtOH. Not only does EtOH have clearly identified acute effects both in vivo and in vitro,
but multiple forms of EtOH-induced plasticity develop in the SCN in response to different
drinking paradigms. While many labs have investigated the cellular changes that occur
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during tolerance, none have demonstrated changes across multiple forms of tolerance as
well as withdrawal induced sensitization within a cohesive set of experiments.
Many studies, including this one, have demonstrated that the effects of EtOH are
extremely varied, across time and across brain region. In light of this, future investigations
evaluating novel targets for AUD should consider using multiple drinking models that
compare different drinking durations. Assessing the effects using a single paradigm may
reveal only some of the critical changes induced by EtOH consumption, and may limit the
translational potential of the research.
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Figure 4.1 The timeline of overnight/10 days of EtOH, 21 days of EtOH, and EtOH
withdrawal in the SCN. Under normal conditions, the glutamate light in vivo or glutamate
in vitro phase shifts the clock during the early night (phase delays) or late night (phase
advances). Further down the timeline represents the development of rapid tolerance and
chronic tolerance after an overnight binge or 4h access for ten days. SCN tissue becomes
tolerant to inhibitory effects of EtOH during these conditions. The cellular actions that
promote this response are still under consideration and thus no figures represent these
two EtOH induced plasticities. Next, After 21 days of 4h EtOH access, EtOH induced
plasticity leads to an increase in the ratio of total protein expression of NR2B to NR2A.
Though this change is not required for tolerance as an increase in the NR2B to NR2A
expression ratio does not occur within the timeframe for tolerance development (overnight
for rapid or 10 days of 4h access for chronic), it may be a prerequisite of EtOH withdrawal
induced plasticity. During withdrawal (dotted line on the timeline), less glutamate is
needed to induce phase shifts, which is evident of EtOH withdrawal induced
hypersensitization to glutamate. At the cellular level, increases in the NR2B:NR2A ratio
persist in addition to increases in phosphorylation of the Y1472 residue of the NR2B
subunit. Upstream, increases in total protein expression of mBDNF and phosphorylation
of Tyr 706 of TrkB receptors likely promote the increase in Y1472 phosphorylation. These
changes may be in part due to prolonged and sudden abstinence from EtOH, allowing for
compensation at the level of TrkB and NMDA receptor signals, and thus leading to SCN
neuron hyperexcitation. These changes should promote increases in synaptic NR2Bcontaining NMDA receptors as well as other receptors and second messengers that were
not assessed in this project.
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